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Phagocytes remove apoptotic cells during development and eliminate pathogens in 
the immune system. The underlying molecular and cellular mechanisms, particularly 
the differences between macrophages and non-professional phagocytes like glia, are 
not well understood. We used novel cell-based assays to screen phagocytic function 
of candidate genes assembled from literature and our genome-wide transcription 
profiling of Drosophila melanogaster embryonic glia.  
Gene function was knocked-down by RNAi and phagocytic efficiency assessed by 
flow cytometry; to explore functional specificity, we offered not only bacteria, but also 
apoptotic cells and beads as 'food'. To validate results in vivo, we analysed glial 
clearance of apoptotic neurons in embryonic development and immune clearance of 
bacteria in adult flies using both genetic mutants and transgenic RNAi.  
Our screen provides a cross section of the different steps of phagocytosis from 
recognition to engulfment and phagosomal degradation. For the recognition of 
apoptotic cells, we confirm the involvement of known factors, such as the chaperone 
Calreticulin and phosphatidylserine-binding Annexin, and identify new players, such 
as NIMA for macrophage and SANTA MARIA for glial corpse clearance. We find 
components associated with vesicular trafficking including the v-SNARE 
Synaptobrevin and the cytochrome Cyp4g15 to be required for corpse clearance. 
Unexpectedly, receptors known for bacterial recognition, such as PGRP-LC and 
TEP2, are also strongly required for apoptotic clearance. Conversely, receptors 
previously implicated in apoptotic cell recognition are also required in bacterial 
clearance (SIMU, Draper), revealing cross-specificity of the system. Our work 
represents the first systematic and comparative assessment of the molecular 
repertoire of different types of phagocytosis, and, with the identification of many new 
players, lays the groundwork for a mechanistic dissection of bacterial and corpse 






Während der Entwicklung eines Organismus entfernen Phagozyten apoptotische 
Zellen, aber sie beseitigen auch Krankheitserreger im Immunsystem. Die 
zugrundeliegenden molekularen und zellulären Mechanismen, insbesondere die 
Unterschiede zwischen Makrophagen und nicht-professionellen Phagozyten wie 
Gliazellen, sind weitestgehend unklar. Wir haben neuartige Zellkultur-basierte 
Assays entwickelt, um die Phagozytosefunktion von 86 Kandidatengenen zu testen, 
die wir aus der Literatur sowie unserem Expressions-Profiling in embryonalen 
Gliazellen von Drosophila melanogaster zusammengestellt haben. 
Die Genfunktion wurde durch RNAi herabgesenkt und die Phagozytoseeffizienz 
wurde mittels Durchflusszytometrie untersucht; um die funktionelle Spezifität der 
Gene zu erkunden, haben wir nicht nur apoptotische Zellen, sondern auch Bakterien 
und mikroskopische Kügelchen als „Essen“ angeboten. Mit Hilfe von Null-Mutanten 
und transgenem RNAi wurden die Ergebniss in vivo validiert. Um die Phagozytose 
apoptotischer Zellen testen, haben wir untersucht, wie Makrophagen und Gliazellen 
tote Zellen während der Embryonalentwicklung entfernen, während zur 
Untersuchung der bakteriellen Phagozytoze adulte Fliegen mit Bakterien infiziert 
wurden.  
Unser Screen liefert einen Querschnitt durch die verschiedenen Schritte der 
Phagozytose von der Erkennung und Einverleibung bis zum phagosomalen Abbau. 
In Bezug auf die Erkennung von apoptotischen Zellen reproduzieren wir die 
Beteiligung von bekannten Faktoren, wie zum Beispiel des Chaperons Calreticulin 
und des Phosphatidylserin-bindenden Annexins, andererseits identifizieren wir neue 
Akteure wie NIMA für Makrophagen und SANTA MARIA für Gliazellen. Außerdem 
zeigen wir, dass Vesikeltransportkomponenten einschließlich der v-SNARE 
Synaptobrevin und des Cytochroms Cyp4g15 für das Fressen apoptotischer Zellen 
erforderlich sind. Überraschenderweise werden Rezeptoren wie PGRP-LC und 
TEP2, die für die Erkennung von Bakterien zustaendig sind, auch für die 
Phagozytose von apoptotischen Zellen benötigt. Umgekehrt sind Faktoren, die als 
Rezeptoren für apoptotische Zellen bekannt sind (SIMU, Draper), auch für die 
Phagozytose von Bakterien notwendig, wodurch eine grundlegende Kreuz-Spezifität 
des Systems zutage tritt. Unsere Arbeit liefert die erste systematische und 
vergleichende Analayse des molekularen Repertoirs der verschiedenen 




den Grundstein für ein mechanistisches Verständnis der Phagozytose von 




















1.1 Evolution of phagocytosis, function in development and 
immunity 
Phagocytosis is an evolutionarily ancient process used by unicellular organisms 
(protozoa) including amoebas and ciliates for nutrient uptake (Dzik 2010). In 
multicellular animals, single cells proliferate and differentiate into organisms, 
consisting of specialized cell types carrying out different functions like digestion and 
reproduction. However, during these processes of cell division and proliferation 
mistakes occur and unwanted cells are created. These superfluous cells kill 
themselves through programmed cell death/ apoptosis for the greater good of the 
organism (Koonin & Aravind 2002). Multicellular organisms are also exposed to the 
constant threat of exploitation by parasitic microorganisms that invade the animal. 
What happens to the dying cells and the invading pathogens? Metazoans need to 
remove extra cells formed during development and differentiation, as well as 
senescent cells and cells damaged or altered by pathological processes such as 
trauma, cancer or infection. As organisms became multicellular, it was therefore 
necessary to have a system of self-surveillance in place to ensure proper 
development and homeostasis. This task of removing dangerous self and non-self 
from the organism is carried out by eating cells called phagocytes, and freely moving 
cells with phagocytic features are present in all multicellular organisms (Danilova 
2006; Dzik 2010; Hartenstein 2006). In the simplest metazoans, sponges and 
cnidaria, amoebocytes and interstitial cells, respectively, eat apoptotic cells and 
pathogens – but these cells also perform other functions including digestion and 
gametogenesis  (U. Technau et al. 2003; David et al. 2005; Agnello & Roccheri 
2010; Custodio et al. 1998). With the evolution of higher body plans and the complex 
developmental generation of different cell types, the demand for apoptotic removal 
and tissue homeostasis increased manifold. Microorganisms that specifically infect 
and damage host animals also coevolved simultaneously. This arms race between 
hosts and microorganisms, as well as the increasing developmental and homeostatic 
load of apoptotic/ damaged/ altered cells, necessitated an increasingly sophisticated 
immune system with more specialized and efficient phagocytes that could sense, 
find and engulf a target, and therefore distinguish between healthy self, dangerous 




types retained or secondarily regained the ability to phagocytose; these cells are the 
so called non-professional phagocytes, which do not actively search for a target, but, 
if in the vicinity of a dying cell or a pathogen, can perform the task of eating 
(Williams-Herman & Werb 1999; Rabinovitch 1995; Gregory & Pound 2011). 
Research in two of the major genetic animal models, the nematode worm C. elegans 
and the fruit fly Drosophila melanogaster provided important insight into the 
mechanisms and evolution of phagocytosis. In C. elegans, development is highly 
deterministic and the number of cells that undergo apoptosis is exactly 
predetermined: 131 cells die in hermaphrodites and 147 in male animals.  Since C. 
elegans does not possess professional phagocytes, it is the neighbors of the dying 
cell that engulf the corpse (Gumienny & Hengartner 2001). In contrast, Drosophila 
does possess professional phagocytes, which are called haemocytes and are very 
similar to vertebrate macrophages (Lemaitre & J. A. Hoffmann 2007). What do these 
phagocytes eat? Nervous system development is a process with particularly high 
apoptosis rates, and the proportion of dying cells increases continuously throughout 
evolution: while almost no cells die during nematode development, around 50% of 
neurons die in the Drosophila central nervous system (CNS), and up to 80% of 
neurons kill themselves in vertebrates, because they have not received the right 
survival signals, not migrated to the right place or not innervated the right tissue 
(Buss et al. 2006; Kuan et al. 2000; Rogulja-Ortmann et al. 2007). To create the 
functional complexity of a healthy brain it is particularly important to efficiently 
remove unwanted cells, and the Drosophila embryo has proven as an excellent 
model to study these processes (Kinchen 2010). At early stages of embryonic 
development it is macrophages that cruise the embryo end efficiently remove 
corpses, however the CNS becomes ensheathed by the blood-brain-barrier at 
embryonic stage 16, after which macrophages can no longer enter the CNS 
(Schwabe et al. 2005). However, cell death in the CNS peaks at these late stages of 
embryonic development – many neurons die and have to be efficiently removed in 
order not to impede proper development. It is a CNS-resident cell type, the cell body 
or cortex glia (hereinafter ‘glia’) that performs this phagocytosis task and is solely 
responsible for clearing dying neurons in the CNS. These non-professional 
phagocytes are, in contrast to macrophages, not motile but remain stationary at their 
CNS positions, probing their surroundings for apoptotic cells with the help of 




1.2 Phagocytosis is a three step process 
Regardless of whether apoptotic cells or pathogens are being cleared, and whether 
macrophages, glia or other cell types perform the task, phagocytosis has some 
uniform steps and features present in all its instances (Stuart & Ezekowitz 2005). 
Phagocytosis occurs in three major steps: recognition, engulfment and degradation 
(figure 1).  
 
Figure 1: Phagocytosis of any particle occurs in three steps.  
Depicted are the three steps of phagocytosis -  recognition, engulfment and 
phagosome maturation - as well as some of the corresponding factors that have 
been investigated in the present work. 
The recognition step requires the phagocyte to sense its target, which can occur via 
plasma membrane receptors binding to ligands on the target particle, or secreted 
bridging molecules/ opsonins labeling target particles for phagocyte recognition. A 
third mechanism completely independent of specific receptor-ligand interactions is 









































transmembrane signaling activates cytoskeletal components to form protrusions that 
enwrap the target in a phagocytic cup. Simultaneously, vesicular trafficking 
components deliver vesicles to the phagocytic cup to extend its surface. Eventually, 
the protrusions fuse and a phagosome is formed. Interactions with the endocytic and 
lysosomal pathways cause hydrolases and proton pumps to be delivered to the 
phagosome, which acidifies and acquires degradative characteristics. Finally, the 
phagosomal content is completely dissolved and absorbed by the eating cell.  
1.3 Phagocytic target recognition 
1.3.1 Pathogen receptors 
Even amoeba express phagocytic receptors, lectins, to sense specific sugar 
residues on the surface of bacteria, and most phagocytic receptor subtypes are 
present in all metazoans (Danilova 2006). In multicellular animals, correct 
recognition of a phagocytic target is crucial for development and maintenance of a 
healthy organism, and a phagocyte therefore needs to identify phagocytic targets 
amongst healthy cells that ought not to be touched. It then needs to distinguish 
between the types of targets it encounters. If the target is a pathogen or otherwise 
dangerous, e.g. a cancerous cell, engulfment needs to be followed by the initiation of 
an immune response in order to alarm the organism about the dangerous objects. 
However, if the target is an apoptotic or damaged cell, phagocytosis has to remain 
‘silent’ without evoking any proinflammatory signaling. Inflammation in response to 
apoptosis is highly undesirable, since it leads to autoimmune reactions and diseases 
(Krysko et al. 2006). The surface features on the target particles are recognized by 
receptors on the phagocytes, enabling them to distinguish between the various 
target particles. The receptors are called pattern recognition receptors (PRRs) and 
identify repetitive molecular patterns on the target surface (Janeway & Medzhitov 
2002). These receptors can be either membrane-bound or secreted, in which case 
they are called opsonins. Certain PRRs do not (exclusively) promote phagocytosis, 
but instead function as signaling receptors to transduce information about the 
recognized particle. What are the molecular patterns recognized by PRRs? A lot of 
the research investigating the mechanics of this process  
has been modeled on vertebrate cultured cells, and many factors have been 
implicated in each of the three steps of phagocytosis (Hamon et al. 2006; Gardai et 




insight into the basic principles underlying pathogen phagocytosis through two 
paradigmal phagocytosis types: phagocytosis through the Fc-receptor for antibody-
opsonized and the integrin/ complement receptor for complement-opsonized 
pathogens. Upon ligation, both receptor types initiate a signaling cascade leading to 
engulfment and target degradation. These cell culture studies for the first time 
investigated the process of phagocytosis and revealed the molecular players 
involved in the different steps of the process, and in particular shed light on the 
interaction between phagocyte and (bacterial) target. Bacterial cell walls contain 
highly ordered sugar structures like mannan, lipopolisaccharides or proteoglycans 
that distinguish them from eukaryotic cells. These structures are recognized by 
different secreted and membrane-bound molecules including collectins, complement, 
peptidoglycan-recognition proteins (PGRPs), CD14 and mannan-binding lectin 
(MBL). Opsonins like MBL and complement label particles for engulfment and are 
recognized by integrin-based complement receptors on phagocytes. Yet other 
receptors like scavenger or toll-like receptors directly interact with the particle 
surface and trigger engulfment. Knockout mice for most of the discovered 
phagocytosis receptors confirmed the crucial function of each individual opsonin and 
receptor: mice deficient in the Fc receptor, CD14, complement receptor, MBL, 
complement components, surfactant proteins and the macrophage mannose 
receptor are more susceptible to different infections due to their impaired innate 
immunity and their defunct pathogen phagocytosis (Haziot et al. 1998; Ip et al. 2008; 
Ravetch & Clynes 1998; P. R. Taylor et al. 2007; Devitt et al. 2004).  
Despite the long coevolution of microorganisms, recognition of these molecular 
patterns on microbes has remained a major mechanism of innate immunity. This is 
probably due to the fact that these receptors have multiple ligand-binding domains, 
which individually bind their ligands only with low affinity. Only recognition and 
binding of repetitive molecular structures, as it is the case on the highly ordered 
bacterial cell walls, promotes engulfment. This synergistic effect enables recognition 
and engulfment even when the microorganism modifies its surface structure to 
evade immune recognition. Also, because multiple receptors need to be engaged by 
a polymer structure, autoimmune phagocytosis of healthy cells is minimized 
(Janeway et al. 1996).  
1.3.2 Apoptotic cell receptors 
Similar to microorganisms, apoptotic cells display surface patterns including proteins, 




phagocytosis of apoptotic cells is a more recent development, but many factors have 
already been found to play a role in the process. Mammalian studies investigating 
individual genes required for phagocytosis of apoptotic cells have been studied in 
pure cell culture studies as well as in vivo. Interestingly it became clear early on that 
a major factor in the process of apoptotic cell recognition is not a protein, but a lipid. 
By inhibiting the interaction between phagocyte and apoptotic cell through 
phosphatidylserine (PS)-containing liposomes it was demonstrated that PS, a 
negatively charged phospholipid, is involved in apoptotic cell phagocytosis (Fadok et 
al. 1992). PS is restricted to the inner leaflet of the plasma membrane in healthy 
cells, but becomes rapidly exposed to the outside of the cell during apoptosis, 
thereby promoting engulfment. PS is the most prominent feature and marker of 
apoptotic cells and has been shown to be recognized by different opsonins including 
ANNEXIN, GAS6 and MFGE8 as well as the phagocyte receptors MER, complement 
receptor (αvβ3-integrin) and BAI1 both in vitro and in vivo (Ravichandran & Lorenz 
2007; Y. Wu et al. 2006; Fadeel 2004). Phospholipids not only get redistributed in 
apoptotic cells, but also oxidized by reactive oxygen species, which are increasingly 
produced in the dying cell (Tyurina et al. 2000; Leitinger 2003). These oxidized lipid 
species need to be recognized by phagocytes, and the scavenger receptor CD36 
has been shown to bind different oxidized phospholipids on apoptotic cells and 
promote phagocytosis by macrophages, dendritic cells and neutrophils (Albert et al. 
1998; R. L. Silverstein & Febbraio 2009). Furthermore, cd36 knockout mice have 
been shown to contain lingering apoptotic cells due to impaired phagocytic removal 
(Greenberg et al. 2006). Lipids play an important role in the phagocytosis of 
apoptotic cells not only as “eat-me”, but also as “find-me” signals: the phospholipid  
lysophosphatidylcholine (LPC) had been implicated in phagocyte attraction to the 
apoptotic cell through inhibition of LPC-generating phospholipase A in apoptotic cells 
and transmigration assays using synthetic LPC (Mueller et al. 2007). The lipids PS 
and LPC are some of the earliest markers of apoptotic cells and should lead to rapid 
identification and engulfment by phagocytes. If, however, elimination of early 
apoptotic cells fails, the apoptotic cell shrinks and exposes normally endoplasmaic 
reticulum (ER)-resident molecules including the chaperones Calreticulin (CRC) and 
Calnexin as well as immature glycoproteins and glycolipids, which have been shown 
to be required for phagocytic recognition in cell-culture as well as genetic knockout 
studies in mice (Gardai et al. 2005; Franz et al. 2006). Lectins on phagocytes 
including C1q, MBL and surfactant proteins A and D have been initially implicated in 




cells and contribute to apoptotic clearance as well (Ogden & Elkon 2006; Ogden et 
al. 2001; Stuart et al. 2005). Apoptotic cells that have not been engulfed at this point 
undergo secondary necrosis, which can lead to the cell’s contents spilling into the 
extracellular space. In necrotic death, the orderly process of corpse elimination is 
abandoned.  Intracellular epitopes become exposed, bind to immune receptors and 
thereby turn into autoantigens, which can lead to autoimmune reactions (Krysko et 
al. 2006; Y. Wu et al. 2006). In contrast, apoptotic cells are engulfed without initiating 
an immune response, but rather lead to immunosuppressive signaling and release of 
anti-inflammatory cytokines (Fadok et al. 1998; Voll et al. 1997; Henson 2005). 
Many receptors contribute to phagocytosis of pathogens and apoptotic cells, and 
some are even shared amongst each other, for example cd14, cd36 as well as 
complement receptors (Siamon 2002).  Phagocytosis of pathogens and necrotic cells 
leads to expression of immune genes like antimicrobial peptides (AMPs) or 
cytokines, while corpse engulfment remains an immunologically silent event.  How 
does a cell, if it employs the same receptors for both types of phagocytosis, know 
when to engage an immune response? One way that has evolved in vertebrates is 
separating the detection of pathogen associated molecular patterns and 
phagocytosis. Vertebrate Toll-like receptors do not promote engulfment, but 
specifically recognize foreign lipopolysaccharide, DNA, RNA and other molecular 
patterns of dangerous invaders and initiate immune signaling. On the other hand, 
there is some overlap between recognition and signaling, as at least CD14 and MBL 
serve as both phagocytosis as well as signaling receptors. It has been shown that 
both receptors promote pro-inflammatory signaling when binding pathogens, but not 
apoptotic cells (Jiang et al. 2005; Ip et al. 2008). How the same phagocytic receptors 
can do both, elicit immune responses when binding to a pathogen and remain silent 
when binding to an apoptotic cells, remains to be elucidated, but is thought to be a 
result of combinatorial input of different receptor-target interactions.   
1.4 Studying phagocytosis in genetic model organisms 
In vivo mouse studies have provided insight into the process of corpse clearance, 
and while some of these studies observed lingering apoptotic cells in the knockout 
mice, other studies were hampered by severe phenotypes like developmental 
defects and autoimmune diseases (Lu & Lemke 2001; Kunisaki et al. 2004; Bader et 
al. 1998; Park et al. 2004; Kunisaki et al. 2004; Roszer et al. 2011; Dahl et al. 2003; 




corpse removal, in many instances a direct proof is missing. Another difficulty in 
genetic knockout studies is genetic redundancy and pleiotropy, as can be seen in the 
instance of integrins. Integrin involvement in phagocytosis of apoptotic cells has 
been shown in cell culture already in 1990 (Savill et al. 1990). Later it has been 
shown that genetic knockout of the alpha 5 subunit is perinatally lethal, because the 
gene is involved in early processes of morphogenesis (Bader et al. 1998). On the 
other hand, knockout of the beta 5 subunit does not show any developmental 
defects, and only old mice develop age-related blindness due to defective 
phagocytosis of apoptotic retinal cells (Nandrot et al. 2004).  
Due to this complexity of the organism and high redundancy of factors in vertebrates, 
genetic invertebrate models including C. elegans and Drosophila have proven 
particularly useful in isolating individual factors. Redundancy is most likely 
attributable to two rounds of genome duplications at the base of the vertebrate 
lineage (Kasahara 2007). The resulting tetraploidization allowed functional 
diversification and redundancy of genes, which facilitate complex body plans, but 
hamper studies trying to understand the function of a specific gene (Makałowski 
2001). However, most gene families present in vertebrates already exist in 
invertebrates, but diversification and gene duplication have not occurred yet, so that 
these gene families in invertebrates consist only of few or even just one member 
carrying out a specific function. For example, the serine protease pathway triggering 
apoptosis/ programmed cell death has sufficient redundancy in vertebrates such so 
that knockout of individual constituents of the pathway, the caspases, does not lead 
to any phenotypes in mice (Lockshin & Zakeri 2004; Lakhani et al. 2006). In C. 
elegans, however, where the genes governing programmed cell death were initially 
discovered, there are only single genes for each functional factor in the genome, and 
knocking out each of these genes leads to the generation of easily detectable 
additional cells that are normally eliminated by apoptosis (Ellis & Horvitz 1986; Lettre 
& Hengartner 2006). It was also in C. elegans that a genetic screen for genes 
affecting removal of apoptotic cells uncovered two partially redundant signaling 
cassettes (Zhou et al. 2001; Gumienny & Hengartner 2001; Gumienny et al. 2001; 
Reddien & Horvitz 2004). Knockout of individual factors from both pathways 
increased the number of unengulfed corpses, and removal of factors from either 
pathway produced an even stronger effect. However, residual phagocytosis was still 
observed in these double knockout mutants, pointing at additional mechanisms 




Table 1: Comparison of methods of RNAi phagocytosis screens in S2 cells. 
 
Shown are different parameters of the protocols for RNAi treatment and 
phagocytosis assays.  
1.5 Phagocytosis in Drosophila 
1.5.1 Phagocytosis screens 
In Drosophila the advent of RNAi and the simple bathing transfection method 
precipitated a number of screens for phagocytic function, which were carried out in 
S2 cells, an embryonic macrophage cell line (Stroschein-Stevenson et al. 2009; 
Rämet et al. 2002; Philips et al. 2005; Agaisse et al. 2005; Ulvila et al. 2011). All of 
these screens were aiming at the discovery of novel factors in phagocytosis of 
pathogens including S. aureus, E. coli, mycobacteria, listeria and yeast. Multiple 
screens used E. coli and S. aureus, therefore allowing for a comparison of the 
screen results. The overlap between the screens is low (figure 2, p. 20). When 
looking at the few genes that were found in more than one screen, for 76% of the 
hits the actual effect strengths are significantly different from each other. These 
discrepancies are likely due to differences in protocols. Between all studies all of the 
relevant parameters differed: dsRNA concentration, duration of RNAi treatment, type 
of phagocytic targets and detection method (table 1, p.  18). Still, these studies 
found a number of genes involved in different types of phagocytosis, such as eater 
and pgrp-lc for E. coli, mcr for yeast and peste for Mycobacterium marinum. 
Ramet 2002 Philips 2005 Kocks 2005 Strosch.-Steve. 2006 Axelrod 2011
Plates [wells] 48 384 48 96 96
dsRNA/ cell [μg] 8 1.5 2 2 0.7












Eating Synchronization 30 min ice spin 30 min ice no spin
E. coli eating time 15 min 45 min 15 min 2 h 2.5 h
S. aureus eating time 20 min - 20 min 2 h 3 h
Beads eating time - - - 20 h 2 h
TrypanBlue yes, pH 5.5 yes, pH 4.4 yes, pH 5.5 no yes, pH 5.5
Fixation no no no yes no
Stainings - Hoechst - Hoechst, α-E. coli -
Read-out FACS Fluorescence reader FACS Microscopy FACS
# of genes tested 1000 12000 45 7000 86
Secondary screening no no no
resynthesis of probes for 
184 hits
secondary RNA for 
19 genes
# of experiments (n) 2-5 3 3 1 3-7
SEM E. coli 14.13 11.09 8.36 - 4.97
SEM S. aureus 12.67 - 4.66 - 3.96




1.5.2 in vivo phagocytosis studies in Drosophila 
Even though these cell-based screens identified a number of novel factors 
specifically required for phagocytosis of each pathogen, in vivo validation has been 
shown only for a small subset of the genes found (Rämet et al. 2002; Bou Aoun et al. 
2011; Kocks et al. 2005). In terms of phagocytosis of apoptotic cells, no screens 
have been published so far, but a small number of in-depth studies elucidated the 
function of individual molecules in the in vivo process. The first Drosophila receptor 
for apoptotic cells discovered is a homolog of the vertebrate CD36 scavenger 
receptor, which had previously been implicated in the recognition and phagocytosis 
of both bacteria and apoptotic cells in vertebrates (Greenberg et al. 2006). Its 
ortholog in Drosophila, croquemort (crq), is expressed in embryonic macrophages 
and required for phagocytosis of apoptotic cells in the developing embryo, illustrating 
the conservation of phagocytic factors throughout evolution (Franc et al. 1996; 
Franc, Heitzler, et al. 1999). Recently a novel class of 13 mostly clustered secreted 
and transmembrane receptors was identified in the Drosophila genome, the NIM 
gene family (Kurucz et al. 2007; Somogyi et al. 2008). Members of the NIM family 
are characterized by a N-terminal cysteine-rich EMI or EMI-like domain, which was 
first characterized in the EMILIN family of glycoproteins of the extracellular matrix 








Figure 2: Overlap between S2 cell phagocytosis screens.  
34 genes have been shown to have an effect on a particular type of phagocytosis in 
at least two different phagocytosis screens. Shown are the differences between the 
results of different phagocytosis screens for A E. coli, B S. aureus and C beads for 
RNAi knock downs of different genes. The colored bars represent the difference 
between results of two screens for a specific gene, the bigger the bar, the higher the 
discrepancy.  Bar values are shown. Significant differences (>15%) are shown in red. 
100% difference would mean that RNAi of a given gene compared to the control 
leads to no reduction in phagocytosis in one screen, and 100% reduction of 
phagocytosis in another.  E. coli phagocytosis has been most extensively studied, 
and some genes have been tested in three screens, in such instances the differently 
colored bars are stacked above each other and are represented by one bar. The 
compared screens are Ramet et al. 2002 (ram), Philips et al. 2005 (phi), Kocks and 
al. 2005 (kock), Stroschein-Stevenson et al. 2006 (str) and the work presented here 
(ax).  
The EMI domain contains a highly conserved CCxGY motif at its C-terminal end. In 
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EGF domains. These two features constitute the core present in all NIM family 
members, and is followed by different types and repetitions of EGF domains (figure 
3, p.  22,  Kurucz et al. 2007). Members of the NIM superfamily can be found in 
many organisms throughout evolution in invertebrates and vertebrates, and while 
some of them have been implicated in phagocytosis, the function of most family 
members is unknown. The first member of this family to be described in Drosophila 
was Draper (DRPR), a transmembrane receptor containing 15 extracellular EGF-like 
repeats and an N-terminal EMI domain (M. R. Freeman et al. 2003). drpr is the fly 
ortholog of the known C. elegans phagocytosis receptor ced-1 and shares sequence 
similarity with the mammalian phagocytosis receptor mfg-e8, both of which have 
been shown to play a role in apoptotic clearance (Naka et al. 2009; Zhou et al. 
2001). DRPR turned out to be the first receptor identified on Drosophila glia and was 
shown to be required for phagocytosis of apoptotic cells in the developing embryo 
and larva, as well as in the adult brain for engulfment of dying neurons, axonal debris 
and degenerating axons after traumatic injury (MacDonald et al. 2006). drpr has an 
intracellular Src phosphorylation motif and interacts with the non-receptor tyrosine 
kinase SHARK for phagocytosis signaling (Ziegenfuss et al. 2008). Interestingly, as 
our lab showed recently, in drpr null mutants apoptotic material accumulates inside 
phagocytes in the embryo revealing that drpr in fact is not required for the 
recognition step of phagocytosis, but rather for phagosome maturation (Kurant et al. 
2008). Finding drpr and identifying its function, for the first time put glia on the map 
as a phagocytosing cell type in Drosophila, and our lab’s interest in glia prompted us 
to intersect our research on glia with questions about phagocytosis. To further 
elucidate the role of glia in embryonic development, our lab had performed an 
expression-based screen for genes differentially upregulated in embryonic glia (H. 
Courvoisier, D. L. J. Fak, N. Rajewsky, and U. Gaul, unpublished data). Different 
phagocytosis genes known from other model organisms were found, including 
members of both C. elegans signaling cassettes together with orthologs of factors 
from vertebrates, pointing to the important role glia play in CNS phagocytosis (figure 






Figure 3: Comparison of EMI (-like) and NIM domain proteins 
(from Kurant et al., Cell, 2008). Typical domain organizations of CED-1, its 
homologs, and other proteins containing an N-terminal EMI(-like) +NIM domain from 
worm,  fly, and human; names of proteins with a demonstrated role in phagocytosis 
are highlighted in grey. Note that in most insect proteins the common EMI (-
like)+NIM core is followed by additional NIM domains, while the vertebrate proteins 
contain tandem arrays of EGF-like repeats similar to those found in CED1 or other 
EGF-type domains. B Sequence alignment of the EMI (-like) +NIM core for all known 
proteins containing this signature from worm, fly, and human. Proteins with similar 
domain organization as represented in A are grouped and bracketed; identical 
residues are boxed in black, similar residues in grey. Note that the EMI(-like) 
domains all share a highly conserved CCxGY motif at the C-terminal end of the 
domain, with invertebrate and vertebrate proteins showing different forms of internal 
truncation relative to the canonical EMI domain as represented by CED-1.  A 
separate superimposed alignment (identical residues boxed in dark blue, similar 
residues in light blue) reveals the stronger similarity of the  Drosophila NimC 
proteins, including SIMU, with the canonical EMI domain; although the two internal 
Cysteines are missing in the NimC proteins, other motifs are preserved.   
This profiling also recovered many novel genes. In particular another member of the 
NIM family, simu, was found to be highly expressed in glia, suggesting a similar role 
to drpr. simu’s extracellular portion is shorter than drpr’s, and in contrast to drpr it 






































































































































      NVC              S          T                                     CC GY        G  C VPIC       C   G  CV P  C C  GY        G    C Consensus (1)
1 13110 20 30 40 50 60 70 80 90 1 0 10 120(1)
PQGD- PPC KKG CIEPGKCECDPGY---- GGK -YCced1 (1)
LDGP- EPC QHG RCISPEKCKCDHGY---- GGP -ACdraper (1)
GGC RG SCVMPDICSCEEGY---- IGK -HCNimA (1)
LEDP- DKC VHG RCIAPNTCQCEPGW---- GGT -NCEGF10 (1)
PEDP- EEC VHG RCVSPDTCHCEPGW---- GGP -DCMEGF 1 (1)
PSDP- QEC VHG RCVAPNQCQCVPGW---- RGD -DCplatelet (1)
RPGR- PPC RNGGSCVQPGRCRCPAGW---- RGD -TCMegf7 (1)
RESQ- KPC LNGGVCVRPDQCECAPGW---- GGK -HCNG3 (1)
GFTDV--- D CGASG-KCLLPNVCLCGKGY-VSRKDHG----HCDNimC2 (1)
PIGL- QQCP HG-FCSSPNTCSCNAGY---- GGI -DCNimC1 (1)
DNIQV--- EACPAHS-YCAEPDRCHCQRGYEPSHHHTTG QLIC-NimC3 (1)
RGCPAHA-SC APDRCECISGYV ARNHQDGSH-YC-Ni C4 (1)





N-terminal EMI domain, which is followed by three cysteine-rich NIM repeats. We 
found simu to be expressed in embryonic glia and discovered that it is required for 
uptake of apoptotic cells, which was dependent on the presence of its EMI domain, 
but not its transmembrane domain, suggesting that SIMU can function as an 
opsonin. 
 
Figure 4: Glia possess the molecular repertoire for corpse engulfment.  
Shown are homologs of known phagocytosis genes that are expressed or 
upregulated in Drosophila embryonic glia, as revealed by affimetrix microarray 
analysis. Constituents of both C. elegans pathways have been recovered in glia 
(blue), as well as homologs to known vertebrate factors (yellow).  
 
Moreover, we found simu to function in the same pathway as drpr in corpse 
engulfment, with SIMU apparently being required for the recognition and DRPR for 
phagosome maturation signaling. Interestingly, both proteins are also expressed on 
macrophages and have similar functions there, underlining the molecular and 
functional similarities between both cell types (Kurant et al. 2008). However, nim 
genes are not only involved in apoptotic cell clearance; members of this family also 
play important roles in immunity. The macrophage receptor eater carries as many as 
28 extracellular NIM repeats and does not have an intracellular signaling domain. 























and adult flies are more susceptible to infection with the Gram-negative pathogen 
Serratia marcescens, pointing at eater’s role in bacterial phagocytosis (Kocks et al. 
2005). Another member of the NIM family was recently identified and implicated in 
bacterial clearance: nimC1, which is similar to simu but contains more extracellular 
NIM repeats, and is required for phagocytosis of S. aureus by larval hemocytes 
(Kurucz et al. 2007). 
These discoveries show that Drosophila is a suitable model to study the specific 
functions of phagocytes and their genes that are already highly specialized here, but 
not yet as redundant as in vertebrates. While the phenomenon of non-professional 
phagocytes including glia has been described in vertebrates, the cellular and 
molecular mechanisms of their apoptotic clearance remain unknown (Parnaik et al. 
2000; Henson & Hume 2006; Hanayama & Nagata 2005).  In Drosophila, glial 
function has been investigated in more depth, and it has become clear that glia are 
highly capable of phagocytosis and are equipped similarly to macrophages in order 
to perform the task, and current research tries elucidate the underlying molecular 
and cellular mechanisms of glial phagocytosis. Three paradigms have been used in 
the field: first, clearance of apoptotic cells in the embryonic nervous system, which 
yielded simu and drpr. Another paradigm is the pruning of degenerating axons in the 
third instar larval mushroom body during metamorphosis, which, apart from the 
involvement of drpr and the cytoskeletal adaptor protein d-ced6, revealed that the 
Ecdysone receptor is required for both apoptosis in the degenerating neurons as well 
as phagocytosis by the enwrapping glia (Awasaki et al. 2006; Awasaki & K. Ito 
2004). Finally, engulfment of severed and degenerating axons after injury, called 
Wallerian degeneration, in the adult brain has been used as a model for glial 
phagocytosis, and drpr as well as its effector shark have been found to play a role 
here (MacDonald et al. 2006; Ziegenfuss et al. 2008). These studies increased our 
understanding of glia as phagocytes, but a lot remains to be learned about the 
mechanics of the process.  
Drosophila macrophages have been predominantly studied in the context of 
immunological questions in cell culture or the adult animal (Brennan & Anderson 
2004; Williams 2007) and are also poorly understood with regard to their function as 
corpse removers. Research in that area focused on embryonic clearance of corpses 
and has identified only few genes so far: in addition to simu and drpr, which are also 
present in macrophages, and the receptor crq, constituents of the calcium signaling 




(Cuttell et al. 2008; Silva et al. 2007). Taken together, our understanding of 
phagocytosis of both apoptotic cells and pathogens by glia and macrophages is 
limited, prompting us the conduct the screen presented here.  
1.6 A novel phagocytosis screen 
Our screen was motivated by the discovery that several known and many putative 
phagocytosis genes from C. elegans and vertebrate models were expressed or even 
upregulated in Drosophila embryonic glia, and the implication of the NIM family 
member simu in glial phagocytosis of apoptotic cells (figure 4, p. 23). simu was 
highly expressed in glia and turned out to be a novel receptor for apoptotic cells, 
solidifying the important role glia play in embryonic corpse clearance and prompting 
us to test other genes differentially expressed in glia for their putative involvement in 
the process.  
 
 
Figure 5: Phagocytosis screen - candidate categories and food types.  
Our screen comprises candidates from different cellular compartments along a 
longitudinal cut through the cell.  Tested food types include charged uncoated beads, 




























As only simu and drpr had been implicated in apoptotic clearance in the Drosophila 
embryo so far, we wanted to identify additional players in the process to shed light 
on the function of glia as phagocytes. Our expression analysis combined with 
previous knowledge about these genes provided a useful pool of candidates 
potentially involved in glial phagocytosis.   
A second motivation for our screen came from the fact that phagocytosis is involved 
in two different processes: clearance of endogenous dead material as well as 
exogenous dangerous invaders. While most studies focused on either the 
endogenous or the immunological aspect, a number of genes had been implicated in 
both processes, and this functional overlap was not only found for intracellular 
components, like cytoskeletal or vesicle traffic factors, but also for receptors, for 
example CD36, integrins and CD14 (Siamon 2002). Moreover, the diversification of 
NIM family members with simu and drpr playing a role in corpse and nimC1 in 
bacterial clearance suggests potential similarities in recognition of apoptotic cells and 
bacteria, leading to the questions: what are the differences between pathogen and 
apoptotic clearance? How specific are phagocytosis genes for a certain target type? 
While there are screens published for phagocytosis of pathogens that compare 
different bacteria, the overlap between these screens is low (figure 2, p. 20), and no 
study has compared apoptotic to bacterial clearance. Cross-specificity of factors has 
become apparent as a result of testing factors in individual assays for pathogen or 
apoptotic cell phagocytosis, never side-by-side in both, and a systematic analysis of 
phagocytosis of different food types is missing. We therefore decided to compare 
phagocytosis of apoptotic cells with phagocytosis of bacteria, and we chose E. coli 
and S. aureus as the canonical representatives of Gram-positive and Gram-negative 
bacteria tested in different previous phagocytosis screens. Additionally we added 
negatively charged polysterene beads as target particles, because they had been 
previously used as model particles in phagocytosis studies and screens to examine 
the engulfment of an, apart from the charge, ligand-free target (Stroschein-
Stevenson et al. 2006). For the question of comparing different foods, the phagocytic 
cell type was of secondary importance. To investigate these two basic questions, 
finding new glial engulfment factors and comparing phagocytosis of different food 
types, we collated a list of 86 genes with genes from our glial expression screen, 
which, based on their similarity to known genes, could play a role in phagocytosis. 
These genes were selected to find new players in glial phagocytosis. To address the 
question of specificity, we picked a number of genes not necessarily expressed in 




We also added known phagocytosis factors from Drosophila and other organisms as 
controls for the different types of phagocytosis. 
 
Figure 6: Screen overview.  
A Workflow of the phagocytosis screen. B Distribution of  effects found for the 
different assays. The cut-off for significance was set to effect strengths >10% and 
concurrence of a q-value from the FDR analysis of <0.05. 
 
In our selection of genes we were not only interested to find new receptors, but also 
wanted to examine intracellular factors and their involvement in phagocytosis. 
Therefore our candidate selection follows a longitudinal axis from secreted and 
surface factors to more downstream events including signaling, cytoskeletal and 
vesicle traffic factors and transcription factors. This selection recapitulates the 
phagocytosis process itself from recognition to engulfment and phagosome 
maturation (figure 5, p. 25).  
As we wanted to test these 86 genes in four assays (apoptotic cells, E. coli, S. 
aureus and beads), we needed to find experimental conditions allowing to test the 
candidates on a medium throughput scale. We decided to use the widely employed 
Drosophila S2 cells, a cell line derived from embryonic macrophages. These cells 
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knock downs and screening through a set of candidates; moreover these cells had 
been used for phagocytosis screens before. Is it sensible to use macrophages to test 
glial genes? Macrophages and glia share many similarities in corpse clearance, not 
only functionally, but also molecularly. Many known macrophage phagocytosis 
factors are upregulated in glia, pointing to these cells having a similar molecular 
repertoire as macrophages (Alfonso & Jones 2002; Sonnenfeld & Jacobs 1995). 
Both simu and drpr, for example, are required in glia as well as macrophages for 
corpse engulfment, illustrating that glia and macrophages share fundamental 
mechanisms during phagocytosis (Kurant et al. 2008). 
To assess whether a glial gene or another candidate was indeed expressed in 
macrophages, we used S2 expression profiles from our lab as well as kindly 
provided by M. Boutros (DKFZ, Heidelberg) and K. Förstermann (Gene Center, 
Munich). Some of the genes we wanted to test in S2 cells seemed not to be 
expressed, including members of the PGRP and NIM families (table 2, p.  29), but 
we still included them in the screen because we suspect these expression data to be 
at least partially false negatives: expression of some of these genes, namely simu 
and pgrp-lc, in S2 cells/ macrophages has been published and my in situ 
hybridizations for nimB4 and nimC3 (not shown) reveal that these genes are 
expressed in embryonic macrophages (Kurant et al. 2008; Rämet et al. 2002). Also, 
all of these genes are expressed in the embryo according to my RT-PCRs as well as 
Flybase high throughput expression data (figure 7, p. 29; table 2, p. 29) and many 
of these genes have been tested and found to be expressed in hemocytes at later 
developmental stages (Royet & Dziarski 2007), suggesting that they are also 
expressed in macrophages in the embryo.  
The primary tissue culture screen was to be followed up by in vivo validation, where, 
depending on a gene’s expression, we would use transgenic RNAi to knock down 
gene function either in glia or macrophages or use available null mutants to test a 
gene’s involvement in phagocytosis. To validate putative new glial phagocytosis 
factors we looked at glial corpse clearance in the embryonic CNS, while for factors 
not expressed in glia but putatively involved in apoptotic clearance, we looked at 
corpse clearance by embryonic macrophages. To assess bacterial clearance by 
macrophages, we infected adult flies with E. coli or S. aureus and monitored the flies’ 
survival over time. In this fashion we were able to find new players in glial and 
macrophage phagocytosis as well as cross-compare the different food types also in 





Figure 7: Expression of the NIM and PGRP gene families in development.  
Shown are RT-PCRs of extracts from different embryonic and larval stages (L1-3), 




Table 2: Expression of genes in the screen.  
Shown are results from microarray data of embryonic glia (Gaul) and S2 cells (three 
different profiles from Gaul, Boutros and Foerstermann) as well as high-throughput 
transcription data from FlyBase. For the NIM and PGRP families additional RT-PCRs 
have been carried out. simu, pgrp-lc and dscam have been shown to be expressed 
in S2 cells or embryonic macrophages in the literature. nimC3 and nimB4 are 









































































































































































Draper ↑ + + + + +
CG7447 ↑ - + + + +
NimB1 - - - + + + +
NimA - - - + + + +
NimC2 - - - +- + +- +
NimB4 - - - + + + + +
Simu ↑ - - - + + + Kurant 2008
NimC1 - - - + + + +
NimB5 - - - + + + +
NimC3 - - - + + + + +
Hemese - - - +- +-






PGRP-SA + + + + +
PGRP-SD - + + + +
PGRP-LC - - - + + + Ramet 2002
PGRP-LE - - - + + + +
PGRP-SB1 - - - + + +
PGRP-LF - + + + + +
PGRP-LA - + + + + + +
PGRP-SC1A - - - + + + +












Annexin IX ↑ + + + + +
EGFR ↔ + + + + +
Croquemort-like ↑ + - - + +
PSR - + + + +
Calreticulin ↑ + + + + +
Croquemort + + + + +
CG10702 ↑ - - - + +
Mdr65 ↑ - - - + +
LDL-R ↑ - - + + +
W ↑ + + + + +
















Dscam - + + + + + Watson 2005
TEP4 ↔ + + + + +
TEP2 + + + + +
TEP1 - - - +- +
Mcr ↔ + + + + +




MMP-1 ↑ + + + + +
Hemomucin ↑ + + + + +
myospheroid ↔ + + + + +





















































































































Dystroglycan ↑ + + + + +
Gliolectin ↔ + + + + +
inflated ↔ + + + + +








Shark ↔ + + + + +
Fps85D ↑ + + + + +
Pvr ↑ + + + + +
J
N
K Jun-related antigen ↔ + + + + +









m Pi3K68D ↔ + + + + +
Pi3K59F ↔ - + + + +
Pi3K92E ↔ + + + + +
Skittles ↑ + + + + +
Sac1 ↔ + + + + +












Rac2 ↑ + + + + +
Vav ↑ + + + + +
Rac1 ↔ + + + + +
Rho1 ↔ + + + + +
Cdc42 ↔ + + + + +
Mig-2-like ↔ + + + + +










Myoblast City ↑ + + + + +
Arp66B ↔ + + + + +
Hem/ Kette ↔ + + + + +
dCED-12 ↔ + + + + +
dCED-6 ↔ + + + + +
SCAR ↔ + + + + +
Short stop ↑ + + + + +
SRA-1 ↔ + + + + +
Crk ↑ + + + + +
Dmoesin ↑ + + + + +










zetaCOP ↑ + + + + +
Gartenzwerg ) ↔ + + + + +
bCOP ↔ + + + + +
Vha14 ↑ + + + + +
α-Adaptin ↑ + + + + +
Shibire ↔ + + + + +
Cysteine proteinase-1 ↑ + + + + +
Cyp4g15 ↑ - - - + +
Syb ↑ + + + + +
E
c
R Eip63E ↔ + + + + +
EcR ↑ - + + + +
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2 Cell-based screen - methodology 
2.1 First and secondary RNAi design 
As we set out to conduct a medium throughput candidate screen for phagocytosis 
factors, we decided to employ the relatively fast RNAi technology to generate gene 
knockdowns. Michael Boutros kindly provided us with the dsRNA library for our 86 
candidate genes. The RNAs provided belong to the second generation dsRNA 
library (Heidelberg 2). In contrast to the first generation library, the design of these 
new probes had been optimized to minimize off-target-effects (OTE). This has been 
achieved by computational tools (NEXT-RNAi, See Material and Methods 8.5, 8.6) 
that excluded probes with ubiquitous trinucleotide tandem repeats (CAN repeats), 19 
nucleotide siRNA matches in other genes, regions of low complexity that are known 
to generate unspecific OTE and short interfering RNAs (siRNAs) containing 
microRNA seeds (Horn et al. 2010).  
 
Figure 8: qRT-PCR of RNAi in S2 cells.  
RNAi efficiency was tested using qRT- PCR. Bars represent fold changes of 
expression in comparison to untreated cells. White bars show fold changes of the 
indicated genes in control GFP RNAi treated cells, black bars in the target RNAi. 
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Despite the optimization of probe design, computational analyses of this library still 
predict 26.6% of probes to have siRNA hits in at least one other gene and 0.5% have 
CAN repeats. Because of the imperfection of RNAi with potential false positives due 
to off-target effects and false negatives due to insufficient knockdowns, secondary 
testing of RNAi results has become the rule. Therefore, we had to evaluate the 
efficiency and specificity of RNAi in our screen. We incubated the cells with the 
dsRNA for three days. To test knock down efficiencies we performed quantitative 
real-time PCR (qRT-PCR) analyses and observed RNA reductions of 60-99%, which 
is in line with what should be expected (Thomas Horn et al. 2010, figure 8, p. 31).  
To make sure that the observed effects are specific, for 19% of our candidates we 
designed secondary RNAs targeting a non-overlapping region of the tested gene, 
creating two independent probes (see 8.5 in Materials and Methods). Effects 
deviating more than 10% from each other, which corresponds to the experimental 
variability, or cases where one result was above and the other below our effect 
threshold of 10% were considered discrepancies between the first and second 
probe. We observed discrepant effects in only 18.75% of the cases, indicating that 
our findings were mostly attributable to specific gene knock downs (table 3, p. 33). 
How does this amount of validation and our level of OTE compare to other studies? 
Before 2006/2007, when a number of papers pointed out the extent of OTE in RNAi 
screens, secondary RNAs were not common for validating results from first round 
RNAi screens. Hits from the first screen were validated by repeating the initial RNAi 
experiment with newly synthesized probes of the same sequence and a different 
functional assay, for example a different reporter construct (Boutros et al. 2004; 
Muller et al. 2005; Gesellchen et al. 2005; Gwack et al. 2006; Eulalio et al. 2007). 
From 2008 on it became more common to validate hits from genome-wide RNAi 
screens using secondary non-overlapping dsRNAs. The number of discrepant 
results in these screens varies greatly from no discrepancies in one study 
(Chittaranjan et al. 2009, 20 genes retested), 15-20% discrepancies (Chew et al. 
2009; T. Liu et al. 2009; Wendler et al. 2010, 22-75 genes retested), ca. 40 % 
discrepancies (Hao et al. 2008; Sathyanarayanan et al. 2008, 176/ 286 genes 
retested) to 84% discrepancies (Guo et al. 2008, 847 genes retested) and is 
therefore somewhat inversely proportional to the number of retested genes. Our rate 
of 18.75% discrepancy for 19 retested genes is therefore in the range of what we 
would expect from the literature.  
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Table 3: Secondary RNA effects are mostly consistent with primary RNAs’.   
 
To assess OTE of RNAi, secondary non-overlapping RNAs were designed against 
19% (16 genes) of the candidate genes. Shown are effects of both RNAs for all four 
assays, the difference between results and the result of the t-test between probes to 
assess significance. Effect deviation >10%, which corresponds to the experimental 
variability, and/ or across our effect threshold of 10% was considered to be a 
discrepancy. Discrepancies were observed in 12 cases or 19% of the genes.  
Effects of genes on 
phagocytosis
Difference 












































Draper -46 -14 -15 -6
Draper_2ndary -39 -14 -11 1 7.2 0.7 4.1 5.0
NimA_1 -19 -9 -9 -7
NimA_2ndary -13 -7 -8 -6 5.2 2.6 1.4 0.6
Simu -16 -19 -11 -5
Simu_2ndary -15 -16 -20 -7 0.7 2.4 8.8 2.5
PGRP-LC -14 -38 -17 -7
PGRP-LC_2ndary -19 -29 -14 -15 5.4 9.1 2.3 7.8
Megalin -13 -14 -8 -4
Megalin_2ndary -10 -11 -7 3 2.6 2.3 0.8 0.9
Mdr65 -10 -16 -10 -8
Mdr65_2ndary -12 -9 -5 -32 1.4 7.2 4.1 23.7
Annexin IX -19 -23 -9 -7
AnnIX_2ndary -13 -15 -3 -9 6.5 8.8 5.6 1.9
Mcr -13 -16 -14 -4
Mcr_2ndary -14 -14 -14 -21 1.0 2.0 0.4 17.0
TEP2 -13 -10 -1 -4
TEP2_2ndary -11 -9 -2 -13 1.9 0.6 0.4 9.5
DSCAM -16 -22 -14 -5
DSCAM_2ndary -11 -21 -15 2 5.3 1.3 0.7 2.9
MMP-1 -13 -12 -6 -8
MMP-1_2ndary -18 -19 -8 -3 5.7 6.6 2.1 5.2
Gliolectin -12 -19 -7 -11
Glec_2ndary -3 -19 -3 -4 9.7 0.3 4.0 6.6
Puckered -2 -28 -21 0
Puc_2ndary 0 -23 -13 -1 1.9 5.4 7.9 1.3
Pi3K68D -23 -25 -18 -10
PI3K68D_2ndary -13 -33 -25 -1 10.0 8.1 6.3 9.2
Rac2 -22 -22 -9 -7
Rac2_2ndary -26 -23 -6 2 3.3 1.2 3.1 4.8
Cdc42 -11 -13 4 -9
Cdc42_2ndary -42 -18 -12 -13 31.0 4.7 15.3 3.5
average difference between probes 6.2 4.0 4.2 6.4
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2.2 Phagocytosis assay and flow cytometry analysis 
We wanted to measure how different RNAi treatments affect the extent to which the 
cells could eat different types of food, so we fed them different types of particles: 
stained apoptotic S2 cells, AlexaFluor488-labeled E. coli and S. aureus and 
carboxylated, negatively charged AlexaFluor488-labeled beads (all three 
commercially available, see 8.2 in Material and Methods).  
 
Figure 9: Analysis of phagocytosis using flow cytometry.  
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Shown are histograms of cell fluorescence distributions. In each plot, the black line 
indicates S2 cells before eating, and the gray filled area the distribution after 
phagocytosis of fluorescent food, therefore the population is shifted to the right. A-C 
Due to quenching of extracellular fluorescence, cells with particles only stuck to 
them, but not inside of them can be distinguished, therefore yielding three 
populations of cells: ‘negative’ without particles, ‘bound’ with particles on the surface, 
and ‘positive’ with particles inside the cell. To evaluate, how many cells ate and how 
much they ate, the percentage and mean fluorescence of the cells with engulfed 
particles (‘positive’) are determined. D Apoptotic cell assay. The eaters alone are 
shown in black. The red fluorescent apoptotic cells alone are shown in red. The grey 
filled area indicates the distribution of eaters after incubation with apoptotic cells. The 
population is shifted to the right. The mean red fluorescence of the eating population 
is determined in order to evaluate, how many apoptotic cells the S2 cells 
phagocytosed. 
 




Figure 10: Flow cytometry phagocytosis screen - examples.  
Unstained cells are incubated with fluorescent ‘food’. Depicted are fluorescence 
(=food) distributions in the eater cells. A. Black, cells without food and grey, after 
eating. The red line in the apoptotic assay  shows the red stained apoptotic cells 
alone. Peaks in the beads assay represent individual ingested beads. B. Effects of 
RNAi. In grey: cells treated with control RNA (GFP); magenta, with candidate RNA. 
Decrease of peak height and a shift to the left represent a reduction of phagocytosis. 
Indicated percentages are normalized effects on phagocytosis as compared to GFP 
RNAi-treated cells. Each assay was performed in replicates and repeated 2-7 times, 
shown is a representative example. 
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Different techniques have been used to score phagocytosis events, namely manual 
and automated microscopical evaluation and flow cytometry (Cronin et al. 2009; 
Stroschein-Stevenson et al. 2009; Rämet et al. 2002; Philips et al. 2005). Notably, 
these screens produced only small overlap among each other, which is probably due 
to the different techniques employed (figure 2, p. 20; table 1, p. 18).  As we wanted 
a fast, quantitative readout for our first round of screening, we decided to use flow 
cytometry for our analyses (8.3 in Material and Methods). Here, we were able to 
analyze thousands of cells for ingested particles each second. The method works as 
follows: the more cells eat fluorescent particles, the more fluorescent they become 
themselves (figure 9, p. 34). The fluorescence for each cell is measured, and in total 
5000 cells are evaluated in that fashion. For the fluorescently labeled beads and 
dead bacteria, quenching of extracellular fluorescence is possible, which means that 
particles outside the eating cells or particles stuck to the eating cells’ surface can be 
excluded from the analysis. Here, only the fluorescence of the eaters with engulfed 
beads or bacteria are evaluated for the amount of engulfed particles. However, the 
‘living’ apoptotic cells cannot be quenched, because they would ingest the quencher 
through endocytosis eliminating their fluorescence. An additional complication is that 
apoptotic cells do not form a uniform particle population like bacteria or beads, but 
display a range of sizes from early apoptotic cells, which have not undergone 
shrinking yet, to shrunken apoptotic cells and finally apoptotic blebs. This 
heterogeneity of the apoptotic cell population leads to a shift in the fluorescence of 
the eater cell population rather than the formation of distinct peaks of negative and 
positive cell populations, as occurs with beads and bacteria (figure 9). Therefore, for 
the apoptotic assay, we determined that the analysis yielding the best differential 
between negative (gfp) and positive control (zCOP) to evaluate the whole population 
of eating cells for the amount of ingested apoptotic cells. For example, RNAi of the 
known phagocytosis gene zCOP reduces the cells’ capacity to engulf red fluorescent 
apoptotic cells, resulting in lower fluorescence of the eater cell population compared 
to the control (gfp RNAi) treated cells. This corresponds to a reduction in 
phagocytosis of ~40 % (figure 10, p. 36). Also, we optimized eating times and the 
amounts of food for all assays to achieve a maximal differential between positive and 
negative control. 




Figure 11: Normalization decreases interexperimental variation.  
Shown are flow cytometry analyses of S. aureus phagocytosis as an example. A 
Intraexperimental variation: duplicates on each plate have the average standard 
deviation of 3%. B raw data variation between same genotypes on different days is 
much higher than between different genotypes on same day requiring normalization. 
C Normalization allows comparison of experiments performed on different days. 
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day # 1 
control (GFP) replicate # 1 590 60 35400 1010 36114 0.02796 11282 26364 0.42794 -1.98 3.071 0
replicate # 2 594 62 36828 1.98
zetaCOP replicate # 1 386 43 16598 285 16397 0.01738 4753 12287 0.38681 -54 2.557 -52.7 0.04853
replicate # 2 395 41 16195 -55.2
day # 2
control (GFP) replicate # 3 374 43 16082 751.7 16614 0.045244 -3.2
replicate # 4 381 45 17145 3.2
zetaCOP replicate # 3 312 27 8424 349.3 8177 0.042719 -49.3
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2.3 Normalization and quality control 
To rule out indirect effects on phagocytosis by RNAi affecting cell viability, we 
determined the size of the cells as a read out to analyze cell apoptosis using the 
forward scatter parameter of the flow cytometer (figure 12, p.40). Apoptotic cells are 
on average 63% smaller than healthy cells. None of the RNAi treatments induced 
apoptosis, showing that a potential reduction of phagocytosis is not a secondary 
consequence of cell death. Because flow cytometry is a highly sensitive method, 
variations in cell states, cell media, apoptotic cell preparations and handling lead to 
experimental variability (figure 11, p.38). To be able to compare different 
experiments, we normalized each experiment against a negative control (gfp RNAi) 
yielding an average standard deviation between experiments of 10% and standard 
error of the mean of 3.5 % (figure 13, p.41). We repeated assays 3-7 times on 
different days and confirmed overall assay performance for each experiment by 
including a positive control (zCOP), which was expected to have an effect on 
phagocytosis greater than 20%. 
2.4 Effect strength 
RNAi does not completely remove gene function, but only reduces it. Depending on 
a gene’s requirement in the cell and the longevity of the protein, this may or may not 
lead to a phenocritical reduction in gene activity. Moreover, phagocytosis is a highly 
redundant process, where the lack of individual genes can be compensated by other 
genes. The worm, even though only 131 cells die during all of development, 
safeguarded their phagocytic removal by two independent signaling cassettes, but 
not even knockout of both of them completely abolishes phagocytosis (Reddien & 
Horvitz 2004). The strongest phenotypes observed in gene knockouts in worm, fly 
and mouse only lead to a two to three-fold increase of apoptotic material in vivo, 
which required us to adjust our expectations for effect strengths, especially since we 
were not creating nulls, but gene knockdowns of presumably varying extent. 
Consequently, although we optimized RNAi treatment protocols, eating durations 
and eater-to-food-ratios, the demonstrated effect strengths are moderate to weak 
(figure 13, p. 41). 
 
 




Figure 12: RNAi of candidate genes does not affect cell viability. 
A Dot plot showing forward (size) and side scatter (granularity) of cells treated with 
RNA against GFP (control, black) and with etoposide for 16 h to induce apoptosis 
(red). Apoptotic cells are 71% smaller than live cells. B Histogram of live cells 
(black), apoptotic cells (red), and cells treated with draper RNAi for 3d, the gene with 
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Changes in the amount of live cells after 3 days of RNAi treatment against specific 
candidate genes.  
The genes with the strongest effects led to a reduction in phagocytosis of roughly 
two-fold for apoptotic cells and bacteria (46% drpr for apoptotic cells, 52% zCOP for 
E. coli, 54% zCOP for S. aureus) and 21% for beads (zCOP). The average effects 
for significant hits ranged from a 14-18% reduction of phagocytosis. However our 
results were highly reproducible, leading us to use a relatively low cut-off of 10% 
change in phagocytosis and concurrent q-values from the false discovery rate (FDR) 
analysis of <0.05. FDR analyses of statistical significance showed significant values 
for 79 (apoptotic cell assay), 75 (S. aureus assay), 51 (E. coli assay) and 27 (beads 
assay) different genes (figure 6B, p. 27). We found the most genes for apoptotic cell 
phagocytosis. This is not due to an internal bias in the candidate selection, because 
even though we selected a number of genes based on their homology to known 
apoptotic cell receptors, we also included many known bacterial receptors, and the 
majority of candidates were not clearly attributable to apoptotic or bacterial clearance 
(figures 5, 14, pages 25, 45). The effects found were largely significant and 










Figure 13: Effects of RNAi knock downs of candidate genes on phagocytosis 
of different target particles.  
Phagocytosis of A apoptotic cells, B E. coli, C S. aureus and D beads. Bar charts 
represent the mean and the SEM of 5-15 individual experiments for each gene. 
Results are sorted by effect strength. 
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3 Validation of screen results  
We wanted to find new candidates involved not only in the phagocytosis of apoptotic 
cells, but also of bacteria and beads. To assess and correctly ascertain the validity of 
screen results, correct statistical procedures are necessary to estimate the number 
of false positive hits (FDR analysis, Benjamini & Hochberg 1995, figure 14, p. 45). 
To evaluate the quality of our screen results, we applied three commonly used 
measures: firstly, secondary non-overlapping RNAs for 19% of the candidate genes 
were designed and tested, which produced results mostly congruent with our primary 
probes (19% discrepancy, table 3, p. 33). Secondly, our results were subjected to 
comparison with other S2 cell phagocytosis screens in the literature. In a next step 
we conducted genetic in vivo analyses, where we tested whether an identified gene 
plays a role in a given process – not only under the isolated cell culture conditions, 
but also in the complex milieu of a whole organism. 




Figure 14: Results and q-values from the FDR analysis of the cell based 
phagocytosis screen.  
For each food type, the mean of 3-7 independent experiments is shown and the 
effect strength is indicated by a heatmap. The second column for each assay shows 
q-values for the results. Significant results are indicated in blue (P<0.05), non-
significant in white (P>0.05). Boxes around tested genes represent in vivo testing: 
green boxes indicate a confirmatory in vivo result, black boxes a discrepant one. ap, 
apoptotic cells; eco, E. coli; sau, S. aureus; bea, beads.  












inflated -8 0.002 -18 0.001 -9 0.003 -6 0.008
Draper_2ndary -39 0.000 -14
-9
-7
0.001 -11 0.125 1 0.055 mys -16 0.000 -13 0.003 -13 0.001 -8 0.045
NimA_1 -19 0.000 0.034 -9 0.002 -7 0.005 Gliolectin -12 0.010 -19 0.001 -7 0.002 -11 0.002
NimA_2ndary -13 0.013 0.033 -8 0.013 -6 0.048 Glec_2ndary -3 0.045 -19 0.001 -3 0.084 -4 0.006
NimB1 -20 0.000 -14 0.003 -10 0.002 -5 0.022 Hemomucin -18 0.002 -14 0.005 -8 0.013 -5 0.022








Shark -21 0.000 -10 0.017 -9 0.002 -11 0.007
NimB4 -20 0.013 0 0.149 -5 0.020 -8 0.018 Fps85D -18 0.000 -19 0.001 -7 0.001 -10 0.042
NimB5 -15 0.000 -14 0.003 -7 0.005 -8 0.005 Pvr 6 0.032 3 0.151 45 0.000 -2 0.094




Jra -13 0.000 -12 0.024 -14 0.002 -8 0.135
NimC2 -4 0.003 -5 0.013 -12 0.000 -10 0.001 Puckered -2 0.060 -28 0.000 -21 0.039 0 0.263
NimC3 -14 0.000 -5 0.033 -7 0.022 -8 0.024 Puc_2ndary 0 0.094 -23 0.005 -13 0.021 -1 0.232











Sktl -15 0.001 9 0.018 3 0.059 -3 0.022
Simu_2ndary -15 0.035 -16 0.029 -20 0.001 -7 0.094 Pi3K92E -17 0.000 6 0.071 -2 0.041 0 0.241
CG7447 -20 0.000 -1 0.152 -14 0.001 -5 0.022 Pi3K68D -23 0.001 -25 0.000 -18 0.000 -10 0.007










PGRP-LA -10 0.013 -10 0.026 -8 0.021 -14 0.023 Pi3K59F -21 0.000 -21 0.000 -16 0.000 -4 0.128
PGRP-LC -14 0.000 -38 0.000 -17 0.000 -7 0.004 PTEN -8 0.003 -24 0.000 -16 0.000 -1 0.134
PGRP-LC_2ndary -19 0.002 -29 0.000 -14 0.001 -15 0.009 Sac1 -13 0.000 -12 0.014 -5 0.049 -5 0.118









Rho1 -16 0.000 -17 0.003 -12 0.002 -8 0.035
PGRP-LF -11 0.000 -8 0.046 -16 0.001 -13 0.038 Rac1 -15 0.001 -16 0.003 -13 0.002 -3 0.047
PGRP-SA -22 0.000 -17 0.019 -13 0.001 -7 0.036 Mtl -12 0.001 13 0.029 -2 0.089 -7 0.013
PGRP-SB1 -15 0.009 0 0.158 -15 0.002 -10 0.008 Rac2 -22 0.002 -22 0.000 -9 0.002 -7 0.005
PGRP-SB2 -8 0.009 -14 0.009 -8 0.012 -12 0.001 Rac2_2ndary -26 -23 0.002 -6 0.027 2 0.013
PGRP-SC1A -9 0.001 -9 0.099 -11 0.008 -6 0.045 Cdc42 -11 0.002 -13 0.016 4 0.061 -9 0.008












Megalin -13 0.021 -14 0.070 -8 0.085 -4 0.045 Vav -19 0.000 -24 0.000 -13 0.002 -6 0.009
Megalin_2ndary -10 0.000 -11 0.018 -8 0.021 3 0.028 Trio -9 0.001 -26 0.000 -16 0.002 -9 0.022










Hem/ Kette -17 0.000 -18 0.008 -2 0.084 -11 0.027
CG10702 -10 0.003 -16 0.003 -8 0.002 -6 0.002 SRA-1 -16 0.000 -21 0.000 -12 0.000 -2 0.196
Crq -10 0.001 -24 0.001 -11 0.000 -7 0.001 dCED-6 -16 0.000 -8 0.046 -15 0.001 -10 0.007
Santa maria -16 0.000 -21 0.001 -6 0.007 -8 0.000 Crk -12 0.000 -10 0.002 -2 0.084 -20 0.001
Crc -10 0.000 -4 0.106 -8 0.006 -1 0.230 dCED-12 -18 0.000 -20 0.001 -16 0.004 -3 0.135
PSR -14 0.005 -9 0.013 0 0.134 -7 0.017 Mbc -25 0.000 -18 0.006 -9 0.002 -10 0.027
EGFR -17 0.000 -15 0.009 -15 0.000 -3 0.157 Arp66B -19 0.000 -17 0.006 -2 0.069 2 0.128
Mdr65 -10 0.010 -16 0.000 -10 0.001 -8 0.013 SCAR -18 0.000 -5 0.087 -12 0.003 0 0.263
Mdr65_2ndary -12 0.000 -9 0.029 -5 0.075 -32 0.000 Shot -16 0.000 -11 0.029 -9 0.002 -12 0.004
W -6 0.025 -18 0.000 -1 0.099 -1 0.231 Moe -7 0.001 -1 0.165 3 0.086 -7 0.001
Annexin IX -19 0.001 -23 0.000 -9 0.000 -7 0.008 Cora -4 0.016 -20 0.001 -15 0.000 -5 0.034



























Mcr -13 0.000 -16 0.000 -14 0.002 -4 0.036 CP1 -10 0.007 2 0.135 -9 0.002 10 0.036
Mcr_2ndary -14 0.000 -14 0.007 -14 0.006 -21 0.005 Cyp4g15 -13 0.006 -5 0.005 -9 0.002 -1 0.230
TEP1 -9 0.000 -7 0.036 -9 0.000 -7 0.003 a-Adaptin -16 0.000 -18 0.000 -14 0.000 -17 0.008
TEP2 -13 0.000 -10 0.008 -1 0.092 -4 0.049 shi -14 0.000 -17 0.003 -11 0.001 -11 0.083
TEP2_2ndary -11 0.008 -9 0.009 -2 0.094 -13 0.011 Vha14 -16 0.000 -19 0.000 -12 0.001 -10 0.008
TEP4 -14 0.000 -7 0.033 -10 0.001 -4 0.035 Syb -14 0.014 -38 0.001 -22 0.000 -11 0.007
dSR-CI 3 0.054 -21 0.002 -12 0.001 -11 0.001 betaCOP -23 0.000 -36 0.002 -32 0.001 -9 0.001
DSCAM -16 0.000 -22 0.002 -14 0.040 -5 0.066 zetaCOP -35 0.000 -52 0.000 -54 0.000 -21 0.000
DSCAM_2ndary -11 0.000 -21 0.003 -15 0.003 2 0.066
E
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Malvolio -1 0.081 -29 0.000 -20 0.000 1 0.231 Eip63E -11 0.002 -8 0.073 -1 0.111 -8 0.011
MMP-1 -13 0.002 -12 0.014 -6 0.026 -8 0.051
MMP-1_2ndary -18 0.001 -19 0.002 -8 0.013 -3 0.023
TIMP -15 0.000 -4 0.057 -18 0.001 -18 0.001
Dg -10 0.000 -16 0.005 -1 0.123 -3 0.170
-60% -50% -40% -30% -20% -10% -0% +10% +20% +30% +40%
Effect on phagocytosis
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3.1 In vivo validation – candidates and methodology 
The recent generation of a genome-wide transgenic RNAi library in Drosophila now 
allows for relatively simple and fast conditional gene inactivation in vivo. Recent 
screens used this new technology and combined tissue culture RNAi with in vivo 
RNAi, thereby trying to confirm cell culture results in the whole organism, and we 
decided to use this combined approach for our screen as well (Saj et al. 2010; Port 
et al. 2011). Our cell-based screen systematically compared eating of different types 
of food including apoptotic cells for the first time. We were interested in learning 
whether the candidates yielded from the screen are also relevant players in vivo and 
therefore proceeded to genetic testing in the whole fly. We selected 18 genes that 
seemed the most interesting to us, and took genes from different cellular 
compartments (figure 21A, p. 84). Most of the genes picked had been described in 
other functional contexts, but never implicated in phagocytosis before. Five genes 
were new and had never been implicated in any functional process. Like the initial 
selection, the genes we picked for in vivo testing were intersected from different lines 
of interest: first and foremost we chose genes highly expressed in glia, because 
investigating their function was our main motivation for the entire endeavor. However 
we also included promising candidates based on the fact that they had not been 
functionally described yet or had shown unexpected cress-specificity in the cell-
based screen.  
The cell-based screen provided us with a list of interesting candidates potentially 
involved in phagocytosis of apoptotic cells and bacteria. As we wanted to specifically 
find new factors for apoptotic clearance in the developing nervous system, we 
proceeded to test the most interesting candidates in vivo, using the Drosophila 
embryo as a model system. We were very surprised to find in our cell-based screen 
that many of the tested genes were not required exclusively for one type of 
phagocytosis, in particular apoptotic cell receptors, but also for engulfment of at least 
one type of tested bacteria. Additionally, we found some factors that had never 
before been implicated in phagocytosis of bacteria. To see whether these cell-based 
findings track in vivo, we tested whether adult flies lacking any of these factors 
become more susceptible to bacterial infection. Consequently, because of the 
amount of cross-specificity we found in our screen, we tested all 18 genes in at least 
two in vivo assays: apoptotic clearance in the Drosophila embryo, either in glia or in 
macrophages and bacterial clearance by infection of adult flies through injection with 
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live E. coli or S. aureus, and monitoring fly survival as an effect of phagocytic ability 
(figure 6A, p. 27). 
To test gene function in vivo, we used available viable null mutants (simu, drpr, pgrp-
lc, pgrp-sa) or transgenic RNAi lines (VDRC Vienna, Dietzl et al. 2007) expressed in 
macrophages (crqGal4) or glia (repoGal4). Whether a given gene was knocked 
down and tested in glia or macrophages depended on a gene’s expression, which 
we inferred from our glial expression data combined with three S2 cell profiles from 
our lab, Michael Boutros, and Klaus Foerstermann, and our own RT-PCRs (figure 7, 
p. 29; table 2, p. 29). UAS-dicer2 was co-expressed to enhance RNAi efficiency. If 
available, we used the latest generation of transgenic RNAi lines (KK), which carry 
the RNAi transgene in a specifically targeted genetic locus, and are therefore more 
likely to significantly decrease the overall rate of position effects leading to false 
positives and negatives. In addition, these transgenes carry introns, which enhance 
their RNAi efficiency and therefore reduce the number of false negatives. The KK 
lines are considered to present a significant improvement over the first generation of 
VDRC RNAi lines (GD lines), which, due to random insertion in the genome leading 
to variable transgene expression, were estimated to create phenotypes only in 60% 
of the cases (Dietzl et al. 2007).  
3.1.1 In vivo apoptotic assay 
In Drosophila development, apoptosis occurs in three major waves, in mid- to late 
embryogenesis, midpupa and then in the early adult (Thummel 2001). In particular 
the development of the nervous system generates many superfluous neurons, which 
have to be removed by phagocytes. While macrophages are responsible for 
apoptotic clearance during earlier stages of embryogenesis, the nervous system 
becomes ensheathed by the blood-brain-barrier at stage 16 and macrophages can 
no longer enter. Then the CNS-resident, astrocyte-like cell-body glia take over the 
task, as our lab and other studies have demonstrated (Sonnenfeld & Jacobs 1995; 
Kurant et al. 2008; M. R. Freeman et al. 2003). Along with the ectoderm, 
macrophages and glia are the three main phagocytic cell populations in the 
Drosophila embryo, and we can individually assess the clearance function of glia and 
macrophages in the embryo. Our initial goal was to find new glial factors, and our 
candidate selection for in vivo testing reflects that: 10 of the 18 chosen genes are 
upregulated in glia and were consequently tested in vivo in the glial assay in the 
embryo (table 2, p. 29). The remaining eight genes were bacterial receptors known 
to be expressed in macrophages or new genes, for which we presumed macrophage 
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expression based on the S2 expression data from Michael Boutros or RT-PCRs of 
whole embryos (figure 7, p. 29; table 2, p. 29). According to a gene’s expression we 
knocked it down either in glia or in macrophages using specific drivers. In addition 
we used four available null mutants. To test apoptotic clearance in loss- of- function 
(lof) animals, we collected Drosophila embryos and aged them till stage 13 for the 
macrophage assay, when the macrophages can still freely move around and are not 
restricted yet in their range of motion by the developing CNS, or stage 16 for the glial 
assay, when the CNS is ensheathed and glia are responsible for apoptotic clearance 
(figure 17, p. 56; figure 18, p. 65). We were not interested in comparing 
macrophages to glia, but our goal was rather to find new players for both cell types, 
therefore we knocked down gene function either in glia or in macrophages. Embryos 
were fixed and stained with an antibody specific for activated Caspase-3 to detect 
apoptotic cells. To assess macrophage clearance of corpses in stage 13 embryos, 
we imaged whole embryos laterally using confocal microscopy and 50 slices were 
recorded with a total thickness of 57 µm. We analyzed glial phagocytosis by imaging 
the nervous system in stage 16 embryos and taking 35 confocal slices with a 
thickness of 17 µm. Confocal stacks were processed using Imaris 3D software 
creating isosurfaces around the apoptotic material, from which calculation of number 
and total volume of particles is possible. As controls, we tested the driver line 
crqGal4; UAS-dicer by itself as well as crossed to a seemingly non-functional RNAi 
line from the old (GD) library of VDRC lines, UAS-Mdr65-RNAi. As this line engages 
the RNA degradation machinery in a similar manner to the other RNAi lines, these 
flies have a more similar background to the test candidates and are therefore a more 
appropriate control. We imaged and analyzed 8-19 embryos for each genotype and 
assessed statistical significance using one-way ANOVA and Dunett’s post test. 
3.1.2 In vivo bacterial assays 
Adult flies were aged for four or five days and injected with live E. coli or S. aureus 
(see 8.6 in Materia and Methods). We monitored fly survival as a read-out of 
phagocytic capacity, as previously  reported (Bou Aoun et al. 2011; S. Meister et al. 
2009; Shinzawa et al. 2009; Brandt et al. 2004; Cuttell et al. 2008; Clark & Bavoil 
2002; Garver et al. 2006). S. aureus is highly pathogenic to flies and kills even wild-
type flies with a t/2 of 4 days. However, removal of specific phagocytosis factors like 
the known Gram-positive recognition molecule PGRP-SA, which we used as a 
positive control in each experiment, increases the relative risk of death fourfold, with 
half of a cohort dead after 2.5 days (figure 19A, p. 67). In contrast, E. coli is not 
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pathogenic to Drosophila and does not affect viability of wild type flies, therefore any 
faster death of mutant flies reveals a gene’s involvement in the process. A null 
mutation for the known E. coli receptor and Imd pathway effector pgrp-lc strongly 
reduces Drosophila’s immunity to E. coli. pgrp-lc flies have a survival t/2 of 2.5 days 
and were used as positive control in all experiments (figure 20A, p. 68). While we 
were able to confirm cell-based results in vivo using available null mutants, 
unfortunately we were not able to reproduce any effects from the cell-based screen 
using transgenic RNAi. The fact that not even transgenic RNAi of genes known to be 
required for immunity to E. coli, like pgrp-lc, led to any phenotype (figure 20, p. 68), 
suggests that transgenic RNAi does not lead to a phenocritical reduction of gene 
expression for this particular assay, and genes required for immunity to the weak 
pathogen E. coli can only be found in null conditions. For the genes we only had 
transgenic RNAi lines for, we therefore could not effectively assess their requirement 
in an E. coli infection in vivo and we can only make claims for the genes for which we 
had null mutants. To assess whether observed survival data were significantly 
different from each other, we employed the commonly used Cox regression analysis 
of survival returning P-values as well as the Relative Risk of Death (RRD) for 
members of a given test group/ genotype (Cox & Oakes 1984; Mair et al. 2005; 
Vigne et al. 2009).  
3.2 in vivo versus in vitro results 
We tested these 18 genes in two in vivo assays: apoptotic clearance in the embryo 
and adult infections with S. aureus, plus infections with E. coli for the four null 
mutants, totaling 40 tests (figure 21, p. 84). We were able to validate the cell-based 
results for the vast majority of cases (37/40 = 93%), showing that S2 cells serve as a 
useful tool to screen for phagocytosis candidates, and also that our mostly (RNAi 
derived) hypomorphic in vivo conditions were for the most part sufficient to create 
phenocritical states, where we could observe the effects of individual factors. How 
well did our return rate of in vivo versus cell-based compare to other screens? 
Although there is no phagocytosis screen that proceeded to test more than one or 
two candidates in vivo, we can compare in vivo confirmation rates with other studies 
using a combined cell-based an in vivo approach. two studies screened for 
regulators of the Notch pathway or Wingless secretion, respectively, first using tissue 
culture RNAi and then in vivo using transgenic RNAi and scoring eye and/ or wing 
phenotypes (Saj et al. 2010; Port et al. 2011). The Notch pathway study retested 501 
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genes in vivo and confirmed 59% of their cell-based results. The study investigating 
wingless secretion retested 115 genes in vivo and found 26% of genes from the cell-
based screen to also have an effect in vivo. Our in vivo confirmation rate was higher 
than both of these screens (93%). These numbers show that while the transfer from 
cell-based assays to in vivo does not match up perfectly, combining cell-based and 
in vivo RNAi is a useful tool to find new factors in a given process.  
3.3 Consistency with literature  
As a proof of principle, we included multiple genes that were known to play a role in 
phagocytosis of some sorts (figure 15, p. 50). These genes include constituents of 
the two C. elegans signaling cassettes, known cytoskeletal regulators and known 
receptors for apoptotic cells and bacteria. When we look at how our data compare to 
published results, we observe that consistency depends on the data source: results 
from other cell-based screens were mostly reproducible in terms of whether a given 
gene was considered required or not for a specific type of phagocytosis (24/38 tests 
= 63%, figure 15A, p. 54). When we look at the specific effect strengths of a given 
gene knockdown in different screens and compare the data to ours, RNAi of many 
genes, even though they are considered as having an effect in two independent 
studies, leads to significantly different effect strengths (figure 2, p. 20). For example 
zCOP: even though knockdown of this gene significantly inhibit phagocytosis of E. 
coli in three different studies, zCOP RNAi leads to 86% less E. coli engulfment in 
one study, 25% less engulfment in another and 52% less phagocytosis in my screen, 
pointing at the variability of the cell-based studies. However, when we compare our 
in vivo results with published data, which stem from in depth studies in null or 
hypomorphic conditions in model organisms including worm, fly and mouse, our data 
were reproduced without exception (23/23 tests = 100%, figure 15B, p. 50). 
 
Following pages: 
Figure 15: Results of cell-based phagocytosis screen and comparison with 
cell-based and in vivo results from the literature.  
Displayed are effects of RNAi knockdowns of candidate genes for the different food 
types. Shown are means of 5-14 replicates. A green box indicates consistency with 
the in vivo result, black boxes indicates discrepancy. Green L’s indicate consistency 
with cell-based results (A) or in vivo results (B) from the literature, black L’s 
discrepancy.  
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4 Screen outcomes 
4.1 Cell-based screen 
We tested 86 candidate genes belonging to different cellular compartments and 
processes for their involvement in phagocytosis of apoptotic cells, bacteria and 
beads. We recovered many known genes including constituents of the two C. 
elegans signaling cassettes, and other cytoskeletal regulators that were known to be 
important for phagocytosis. We also found genes known from Drosophila 
phagocytosis including simu, drpr and nimC1 (figure 10, p. 36; figure 14, p. 45), all 
of which had previously been shown to play a role in the process. Interestingly, we 
also found novel functions for some of these genes in cases other than the 
previously reported type of phagocytosis. For example we were surprised to find that 
simu is not only necessary for phagocytosis of apoptotic cells, but also for 
phagocytosis of S. aureus; and pgrp-lc not only for E. coli phagocytosis, but also for 
apoptotic cells. This cross-specificity of factors, especially surface receptors or 
secreted molecules known to recognize either bacteria or apoptotic cells, was an 
intriguing and unexpected finding and pertained to a large portion of the tested 
genes (figure 16, p. 54), prompting us to seek in vivo validation. Apart from novel 
functions for previously known genes, we also found new phagocytic functions for 
genes that were known but had never been implicated in this process before, or 
entirely novel genes without any known function. Two examples for such novel 
players are nimA and cyp4g15 (figure 10, p. 36). nimA belongs to the NIM family of 
genes, which also contains simu and drpr, but nimA itself has never been implicated 
in phagocytosis. cyp4g15 is a gene without any known function, but based on its 
homology it is annotated as a cytochrome P450 and it is highly expressed in 
embryonic glia. Here, we report that both genes are specifically necessary for 
apoptotic cell phagocytosis, but not for phagocytosis of bacteria or beads, and we 









Figure 16: Cross-specificity of phagocytosis genes – cell-based screen.  
A-C Effects of specific gene knock downs on phagocytosis in the cell-based screen 
are plotted. The axes represent the effects on phagocytosis of a specific food type. 
The lower left quadrant indicates significant reductions greater than 10% on both 
plotted food types. The number of genes in the quadrant is indicated as well as the 
number of genes exclusively affecting a given pair of food types. A  x-axis: effect on 
phagocytosis of apoptotic cells, y-axis: effect on phagocytosis of E. coli. 38 genes 
significantly reduce both types of phagocytosis by at least 10 %, and out of these, 18 
genes affect only apoptotic cell and E. coli, but not the other types of phagocytosis. 
B x-axis: effect on phagocytosis of apoptotic cells, y-axis: effect on phagocytosis of 
S. aureus. C x-axis: effect on phagocytosis of E. coli, y-axis: effect on phagocytosis 
of S. aureus. D Pie chart displaying numbers of genes affecting single food types or 
combinations of foods. Genes having a significant effect of more than 10% are 
shown. The blues show factors specific to only one type of food. The reds show 
genes affecting 2 types of food. The greys show numbers of genes affecting different 
combinations of 3 food types. Bright red, 8 genes are required for all 4 tested types 
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4.2 In vivo testing 
The process of phagocytosis had not previously been systematically compared for 
different food types, including apoptotic cells. The 18 genes we selected for in vivo 
testing, as in the cell-based screen, are associated with different cellular 
compartments from the surface to more downstream events in the phagocytic 
process (figure 21, p. 84). Using this approach, we were now also hoping to 
functionally dissect phagocytosis of different types of food in vivo using two suitable 
paradigms: developmental clearance of apoptotic neurons and adult clearance of 
infection in the immune system. Another aspect was finding new factors for glia and 
macrophages, both of which are specialized to eat dying cells in the developing 
embryo. Many of the genes chosen for the primary cell-based and then for the 
secondary in vivo screen are upregulated in glia and were therefore also knocked 
down in glia in vivo using the repoGal4 driver and checked for their involvement in 
the process. Non-glial genes were knocked down in macrophages using the crqGal4 
driver. For four of the 18 genes we were able to use available null mutants. Genes 
were selected along a cross-section through the cell, from the cell surface to ‘core’ 
machinery and signaling events. Specifically, the genes chosen include the members 
of the NIM gene cluster, the PGRP gene family, other surface molecules, bacterial 
recognition genes, a matrix metalloproteinase, and genes from vesicle trafficking 
(figure 21, p. 84). Thus, the candidates reflect different aspects of the phagocytic 
process, from recognition through different types of mechanisms and molecules, to 
signaling and phagosome maturation. 
Novel players in Drosophila glial phagocytosis 
 
 56 
5 Novel players in Drosophila glial phagocytosis  
We tested a number of interesting genes, selected on the basis that they were highly 
expressed or even upregulated in glia, showed an effect in the cell-based screen 
and/or were orthologs to known phagocytosis factors from vertebrates, or shared 
sequence similarity to Drosophila genes known to be involved in phagocytosis.  
 
Figure 17: Glial clearance of apoptotic cells - novel players.  
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Embryos of flies with RNAi transgenes expressed in glia (repo-G4) were fixed, 
stained for activated Caspase 3 (α-CM1) and imaged using confocal microscopy. A 
Images represent segments 3-6 of the nervous system in stage 16 embryos. 
Depicted are confocal stacks of 17.5 μm. B Total volume of apoptotic particles was 
measured using Imaris 3D isosurfacing. Bar charts represent total volume of 
apoptotic material. 1-way ANOVA to test for significance. *** P < 0.0001 
5.1 Bridging molecules and receptors 
The mammalian Annexin family comprises 12 calcium or calcium and phospholipid 
binding proteins that perform a range of functions inside and outside cells, including 
intracellular calcium signaling and membrane scaffolding and extracellular 
fibrinolysis and immune signaling modulation. Certain Annexins assume a special 
role in apoptotic clearance, because they bind newly exposed PS on the apoptotic 
cell surface. It is through this opsonization that the corpse is labeled for phagocytosis 
(Gerke et al. 2005). It has been shown that both Annexin (ANN) I and V bind PS, and 
C. elegans deficient for annI show defects in phagocytosis of apoptotic cells, 
confirming the important role of Annexins in apoptotic clearance (Arur et al. 2003). 
The ANN-PS complex is arguably recognized by a PS receptor on macrophages, 
which subsequently engulf the apoptotic cell (Mitchell et al. 2006; Williamson & 
Schlegel 2004). Annexins are conserved throughout evolution and are present in all 
clades of the animal and plant kingdoms. Drosophila possesses three Annexins, IX, 
X and XI. Even though Annexins are presumably ubiquitous due to their role in basic 
processes like calcium signaling and membrane organizing, two of the Drosophila 
Annexins – IX and X – are upregulated in glia, according to our expression profiling. 
When we tested annIX in our cell-based assay we observed a strong reduction in 
phagocytosis of apoptotic cells, suggesting that this gene also plays a role in the 
process in Drosophila (figure 14, p. 45). Transgenic RNAi of annIX in glia confirmed 
this observation: embryos with a knock down of this factor in glia showed an 
accumulation of corpses in the embryonic nervous system (figure 17, p. 56). This 
shows that annIX is required for phagocytosis of apoptotic cells in Drosophila as 
well, underlining the evolutionary conservation of this bridging molecule and its 
important role in labeling unwanted cells for engulfment.  
Another known player from vertebrate cells is crc. This classical ER protein does not 
only act as an ER-resident chaperone, but has also been found to be involved in 
various other processes including adhesion, migration, immunomodulation and 
phagocytosis (Gold et al. 2010). In particular it has been shown that CRC can act in 
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trans as an ‘eat-me’ signal exposed on apoptotic cells as well as in cis as a receptor 
for collectins binding apoptotic cells on the phagocyte (Gardai et al. 2005; Vandivier 
et al. 2002). crc knockdown had a mild effect on our cell-based apoptotic clearance 
assay (figure 14, p. 45), but transgenic RNAi in glia in vivo magnified this finding: crc 
is highly upregulated in glia, and when we knocked down gene function using 
transgenic RNAi we observed that crc-deficient glia have a reduced capacity for 
engulfment, leading to an accumulation of apoptotic material in the embryonic 
nervous system (figure 17, p. 56). This increase is also interesting, because while 
highly significant, the magnitude was only 1.5 fold, which is somewhat less than for 
other tested factors. This suggests that either knockdown efficiency was low or crc 
function can be at least partly compensated by another gene. Finding annIX and crc 
to be involved in the process was expected but nevertheless exciting, because it 
shows that corpse engulfment is, despite its increasing complexity, an evolutionarily 
conserved process and governed by the same factors in invertebrates and 
vertebrates.  
Finally, we tested two genes based on their sequence similarity with known 
phagocytosis factors in Drosophila: megalin and scavenger receptor acting in neural 
tissue and majority of rhodopsin is absent (santa maria). One of the ‘eat-me’ signals 
newly exposed on apoptotic cells is oxidized low density lipoprotein (LDL), which is 
in turn recognized by specific receptors on phagocytes (Oka et al. 1998; Boullier et 
al. 2001). One of the identified receptors in this process is cd36; removal of this 
factor has been shown to play a role in apoptotic cell clearance in vertebrates, where 
transfection of cd36 into non-phagocytic cells rendered them able to phagocytose 
apoptotic cells (Greenberg et al. 2006). A Drosophila homolog of cd36 is crq, which 
is expressed in embryonic macrophages and is required for phagocytosis of 
apoptotic cells (Franc, Heitzler, et al. 1999). We found a closely related gene, santa 
maria (82% sequence identiy), to be additionally highly expressed in glia and tested 
its role in the process. santa maria was strongly required for phagocytosis of 
apoptotic cells in vitro and in vivo, showing that santa maria has the same function in 
glia as in macrophages (figure 14, p. 45, figure 17, p. 56). crq and santa maria 
therefore seem to have evolved from a common ancestor gene, but both receptors 
preserved their function in corpse clearance, with the difference that santa maria (but 
not crq) is additionally expressed in glia. It remains to be elucidated why the same 
receptor is not reused for both cell types, and why glia do not express crq, but santa 
maria instead.  
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Another intriguing cd36 homolog specifically upregulated in embryonic glia is 
megalin. In addition to its similarity to cd36, megalin contains EGF-like domains, 
which are also present in the known phagocytosis receptor drpr, making megalin an 
overall interesting candidate. We knocked down gene function in embryonic glia and 
found that phagocytosis of apoptotic cells was indeed significantly reduced in the 
nervous system, resulting in many more lingering apoptotic particles (figure 17, p. 
56). We thus showed for the first time that the Drosophila megalin acts as a receptor 
for apoptotic cells on glia in the developing nervous system, underlining the general 
role of cd36-like proteins in apoptotic cell recognition.  
5.2 Extracellular matrix 
The ECM is a crucial element in all animal body plans. It lines all animal organs and 
tissues and provides order and structural integrity to the living organism. It consists 
of a complex meshwork of hydrophilic proteoglycans and glycoproteins promoting 
cell adhesion and cell signaling, anchoring cells and giving them orientation as well 
as survival or death signals. During normal developmental processes the ECM must 
be altered in order for metamorphosis, tissue remodeling or migration through 
barriers to occur, and ECM molecules are sensed by adjacent cells through a 
number of receptors including integrins and Dystroglycan. Degradation of the ECM is 
associated with many diseases including cancer growth and metastasis (Page-
McCaw et al. 2007). As many ECM receptors and associated factors are highly 
upregulated in glia, we included a subset of these genes in our phagocytosis screen 
- another process integral to tissue remodeling and homeostasis. While the integrin 
myospheroid and the lectin receptor gliolectin showed involvement in the process, 
we decided to focus on the intriguing finding that the matrix metalloproteinase 1 
(mmp1) seemed to be required for phagocytosis of apoptotic cells (figure 10, p. 36). 
The MMP family of proteolytic enzymes can cleave almost every component of the 
ECM, and its members are implicated in many ECM remodeling processes during 
healthy and abnormal development and homeostasis. While the mammalian 
genomes contain over 20 MMPs that have mostly redundant functions, Drosophila 
has only two, mmp1 and mmp2, making the functional dissection of these genes 
feasible. It has been shown that null mutants for either of the fly MMPs leads to 
aberrant axon defasciculation in the embryo, perturbing normal nervous system 
development. (C. Miller et al. 2008; Yasunaga et al. 2010). mmp1 has been shown to 
be a secreted molecule, which is expressed in S2 cells as well as in the embryonic 
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CNS. In our glial expression profiling we found mmp1 to be highly expressed in 
embryonic glia, and we decided to test its involvement in phagocytosis of apoptotic 
cells. Our cell-based screen showed a requirement for mmp1 in phagocytosis of 
apoptotic cells, so we decided to check its in vivo function in glia. RNAi of the 
secreted molecule in glia indeed confirmed the cell-based finding: apoptotic cells 
accumulate sustainedly in the embryonic CNS due to a defect in their phagocytosis 
by glial cells (figure 17, p. 56). Vertebrate cell-culture studies had previously shown 
that MMPs can play a role in phagocytosis: in addition to the extracellular 
degradation of the ECM during remodeling processes, phagocytic degradation can 
occur as well (H. Lee et al. 2007). However, it is unclear whether the function of 
secreted mmp1 is indeed akin to a phagocytic receptor, which would necessitate 
another recognition molecule on the phagocyte’s – the glial – surface, or whether the 
protease is instead involved in shearing away the ECM in the CNS providing the 
necessary freedom of movement for the glia to engulf their apoptotic targets. In any 
event, this is the first time a glial-expressed mmp has been implicated in 
developmental clearance of apoptotic cells, pointing at the importance of phagocyte-
matrix interactions during phagocytosis.  
5.3 Signaling and phagosome maturation 
During phagocytosis, it is not enough to just recognize what is to be eaten. The cell 
subsequently needs to perform complex actions to enlarge its surface, stretch its 
‘arms’ and enwrap its target, which requires coordinated signaling and major 
cytoskeletal reorganization. The final stage of phagocytosis is phagosomal 
maturation and degradation of the contained particle into its basic molecular units. 
Proton pumps integrated in the phagosomal membrane acidify the phagosome 
lumen and thereby create the right digestive milieu to dissolve all phagosomal 
content. To this end the phagosome is enriched with proteo-, glyco- and lipolytic 
enzymes, which acquire their hydrolytic capacities at low pH. How is this change in 
phagosomal composition achieved? Phagosomes repeatedly interact with vesicles 
from the endocytic pathway through consecutive fusion and fission events. In this 
fashion the phagosome changes and matures; early endo-and phagosomal factors 
are segregated away into parting vesicles, while late endo- and phagosomal factors 
are delivered by arriving vesicles. These membrane fusion events are executed by 
special membrane proteins on the vesicle and target membranes, SNAREs, forming 
alpha-helical bridges in trans that increase membrane curvature and induce lipid 
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bilayer breaks, which eventually result in vesicle fusion or fission (Zhou & Yu 2008; 
Underhill 2005). One of the core SNARE machinery members is Synaptobrevin 
(SYB) that has been initially described and studied in the context of fast 
neurotransmitter release from presynaptic vesicles at the chemical synapse. syb 
however is required not only for exo-, but also for recycling endocytosis of 
neurotransmitters at the axonal endplate and is generally part of the core membrane 
fusion complex consisting of four SNARE proteins (Jahn & Südhof 1999; Deak et al. 
2004). While syb’s role in neurotransmitter exocytosis had been extensively studied, 
we were surprised to find it highly upregulated in embryonic glia and went on to test 
its possible involvement in phagocytosis, an entirely different process that 
nevertheless requires multiple fusion and fission events as well. The cell-based 
results indeed showed a broad requirement for syb in phagocytosis of all tested 
targets, pointing to an important role of this gene in phagocytosis (figure 14, p. 45). 
In vivo testing of a transgenic RNAi line expressed in glia confirmed this result: knock 
down of syb in glia leads to a significant accumulation of apoptotic cells in the 
embryonic CNS (figure 17, p. 56). This result demonstrates for the first time that syb 
is not only required in neurons for synaptic transmission, but is also involved it in glial 
function. Here, it is a necessary factor in the engulfment process, probably through 
delivery of vesicles to the plasma membrane thereby increasing the phagocytic cup 
surface. 
The cytochrome P450 superfamily comprises a large number of enzymes that 
catalyze monooxidation of substrates with the help of the hem cofactor. They are 
crucial for different metabolic processes including steroid hormone biosynthesis and 
drug metabolism, where they account for ca. 75% of all metabolic reactions (Adams 
et al. 2000; Maïbèche-Coisne et al. 2000). We found cyp4g15 to show strong 
expression in embryonic glia, suggesting a function in these cells. To test this 
hypothesis we knocked down gene function in glia using transgenic RNAi and saw 
that this indeed led to a strong increase of apoptotic material in the nervous system 
(figure 17, p. 56). This shows that cyp4g15 is required for corpse phagocytosis, an 
entirely novel function for cyp4g15 enzymes and cytochromes in general. The exact 
function of Cyp4g15 in phagocytosis of apoptotic cells remains to be elucidated.  
In summary, we successfully tested a set of factors for their involvement in 
developmental corpse clearance by glia. We found homologs of vertebrate factors, 
as well as identified new cd36-family members as players in this highly redundant 
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process, shedding light on how glia manage to quickly recognize and remove 
apoptotic material during brain development. 
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6 Cross-specificity of phagocytic factors 
Many different factors have been implied in various – mostly cell-based – model 
systems in phagocytosis of apoptotic cells, bacteria, beads and other types of 
material. The proteins involved have very different structures and features, and many 
appear to be promiscuous in their ligand choice, binding not only bacteria, but also 
apoptotic cells. However, these findings were rarely made under the same 
conditions, and a systematic evaluation has been lacking. When we found many of 
the genes tested in S2 cells to be cross-specific for different food types, we tested 
the most interesting candidates in vivo.  
6.1 Opsonins 
The first step in phagocytosis is target recognition: a cell needs to sense its food to 
start engulfing it. The longest-range sensors are not receptors, but secreted 
molecules that float in the blood/ haemolymph and bind to phagocytic targets. These 
opsonins have been described in much detail for bacterial recognition, and a major 
class of opsonins are the thioester-containing proteins of the vertebrate complement 
cascade. These factors recognize and bind molecular patterns on the bacterial 
surface, and are in turn recognized by integrin-based complement receptors on the 
phagocyte (Philippe 2004; Danilova 2006; Dzik 2010). Interestingly, Drosophila also 
has a class of thioester-containing proteins, the TEPs. It consists of six genes, tep1-
6, in which tep5 seems to not be expressed and tep6 is commonly known as 
macroglobulin complement related (mcr, Blandin & Levashina 2004). tep2 and mcr 
had been implicated in E. coli phagocytosis by S2 cells, but in vivo lof of individual 
TEPs failed to produce any phenotypes, raising the possibility that these proteins 
can compensate for each other (Bou Aoun et al. 2011; Stroschein-Stevenson et al. 
2006). We tested tep1,2,4 and mcr in our screen, and confirmed the requirement for 
tep2 and mcr for E. coli phagocytosis. tep2 does not play a role in S. aureus 
phagocytosis, as had been shown before, but we surprisingly observed that mcr is 
required for uptake of this bacteria (figures 14, 15, p. 45, 50). This is in line with our 
own in vivo validation, which had never been performed before: transgenic RNAi in 
macrophages leads to a significant acceleration of death in adult flies infected with 
live S. aureus, revealing a novel role for this factor in bacterial phagocytosis (figure 
19, p. 67). Moreover, we were very surprised to find that both tep2 and mcr also 
seem to be required for apoptotic cell phagocytosis, and embryonic analysis of 
apoptotic clearance confirms these findings: lof of mcr as well as tep2 in 
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macrophages leads to a significant increase of apoptotic material in the embryo 
(figure 18, p. 65). This shows that these complement-like factors are not specifically 
recognizing bacteria and yeast, as has been postulated, but are also promoting 
engulfment of apoptotic cells. While complement binding to apoptotic cells has been 
shown in vertebrate cells, we demonstrate here for the first time in vivo that 
complement opsonization is a mechanism for engulfment of apoptotic cells.  
6.2 The NIM family 
The NIM gene family of secreted or transmembrane proteins was recently identified 
as a novel class of engulfment receptors (Kurucz et al. 2007). It contains the 
apoptotic cell receptors simu and drpr, but also the S. aureus receptor nimC1 and 
eater, which is required for phagocytosis of both S. aureus and E. coli phagocytosis, 
suggesting that the nims evolved and diversified from their common worm ancestor 
ced-1 into a family of functionally distinct phagocytosis receptors (figure 3, p. 22). 
However, only three out of the thirteen members have been tested and implicated in 
phagocytosis so far. Because of their different specificities – simu and drpr for 
apoptotic cells, and nimC1 for Gram-positive bacteria – we were interested to 
systematically test the NIM family in all our assays: apoptotic cells, Gram-negative, 
Gram-positive and bead eating. We recovered the known functions of NIM genes, 
but also uncovered novel ones (figures 14, p. 45; figure 15, p. 50). One gene that is 
necessary for apoptotic cell clearance in S2 cells, nimA (figure 10, p. 36), was of 
particular interest to us, as it is most closely related to drpr and therefore seemed a 
good candidate for in vivo testing. nimA contains, similar to drpr, an N-terminal EMI 
domain, followed by one NIM repeat and two EGF-like repeats; it also, like drpr, 
contains a large intracellular portion (figure 3, p. 22). 
 




Figure 18: Macrophage clearance of apoptotic cells - novel players.  
Embryos of flies with RNAi transgenes expressed in macrophages (crq-G4) or null 
mutants were aged, fixed, stained for activated Caspase 3 (α-CM1) and imaged 
using confocal microscopy. A Whole stage 13 embryos are imaged in lateral view. 
Shown are confocal stacks of 57 μm. B Total volume of apoptotic particles was 
measured using Imaris 3D isosurfacing. Bar charts represent total volume of 
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nimA is expressed in the embryo (figure 7) and we found that transgenic RNAi of 
nimA in embryonic macrophages led to a strong increase of apoptotic material in the 
Drosophila embryo (figure 18, p. 65). This confirms our cell-based findings and 
identifies nimA as yet another ced-1 homolog involved in apoptotic clearance. As 
suggested by the cell-based results, we did not find nimA to play a role in bacterial 
clearance (figure 19, p. 67; figure 20, p. 68), showing that it is a specific recognition 
molecule of apoptotic cells.  
A gene which was, however, required for bacterial eating was nimC2, a close 
paralog to nimC1, which is a known receptor for Gram-positive S. aureus. We found 
nimC2 to have a phagocytosis profile very similar to nimC1, which is exclusively 
required for S. aureus clearance (figures 10, 14, 15A), and therefore went on to test 
nimC2 in vivo. Indeed we found that nimC2 knockdown in macrophages increases 
the flies’ susceptibility to S. aureus infection (figure 19, p. 67), but has no effect on 
apoptotic cell phagocytosis (figure 18B, p. 65). This identifies nimC2 as a novel 
specific receptor for Gram-positive S. aureus.  
In summary, we newly identified two specific receptors for very different food types 
through our screen, nimA for apoptotic cells and nimC2 for S. aureus, manifesting 
the important function the NIM family plays in different aspects of phagocytosis, but 
also pointing at the immense redundancy of phagocytosis factors and the general 
importance of the process. While both nimA and nimC2 seem to be specific for their 
respective food types, we made a rather surprising observation regarding our players 
simu and drpr: both genes seemed not only to be required for apoptotic cell eating, 
as we knew already, but also seemed to affect phagocytosis of S. aureus and E. coli 
(figure 10, p. 36; figure 14, p. 45; figure 15, p. 50). To follow up these puzzling 
findings, we tested simu and drpr null mutants in vivo in our bacterial infection assay. 
We could indeed validate the cell-based results in vivo: particularly immunity towards 
S. aureus is strongly compromised in simu or drpr nulls, which die as fast as the 
positive control (flies deficient in the Gram-positive peptidoglycan receptor pgrp-sa), 
pointing at SIMU and DRPR’s ability to recognize Gram-positive bacteria (figure 19, 
p. 67).  




Figure 19: Novel players in bacterial clearance - S. aureus.  
Adult flies with RNAi transgenes expressed in macrophages (crq-G4) or null mutants 
were injected with diluted overnight cultures of S. aureus and survival was monitored 
as a read-out of phagocytic capacity. crq::mdr-65RNAi flies were used as control. 
Shown is the mean of 3-5 independent experiments with the the SEM. A Loss-of-
function of specific genes increases lethality of S. aureus infected flies. A significant 
decrease of survival is indicated in red. B Relative risk of death for flies in indicated 
genotype groups. Significance and Relative Risk of Death were assessed using the 
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Figure 20: Novel players in bacterial clearance- E.coli.  
Adult flies with RNAi transgenes expressed in macrophages (crq-G4) or null mutants 
were injected with overnight cultures of E. coli and survival was monitored as a read-
out of phagocytic capacity. crq::mdr-65RNAi flies were used as control. Shown is the 
mean of 3-5 independent experiments with the SEM. A E. coli is non-pathogenic to 
healthy flies, but kills flies with loss-of-function of specific macrophages genes. A 
significant decrease of survival is indicated in red. B Relative risk of death for flies in 
indicated genotype groups. Significance and Relative Risk of Death were assessed 











































Cross-specificity of phagocytic factors 
 
 69 
Both genes also affected Drosophila’s immunity to E. coli. While control flies are 
completely immune to E. coli infection and remain unaffected by it, drpr and simu 
nulls become susceptible to the infection and start dying after one day, with the 
maximal death in a cohort reaching 45% after one week; at this point control flies are 
all still alive and the positive control, flies deficient in the Gram-negative 
peptidoglycan recognition protein pgrp-lc, are all dead (figure 20, p. 68). Removal of 
simu or drpr has a relatively weak effect on immunity to E. coli infection compared to 
the positive control, pgrp-lc, and most simu or drpr flies remain unaffected by the 
infection. However, the contribution by both receptors to immunity against E. coli is 
significant. These findings are very intriguing, as both genes had only been 
discussed and studied in apoptotic cell clearance paradigms. Their additional 
involvement in bacterial clearance uncovers a fundamental cross-specificity of 
phagocytosis factors, which through as yet unknown interactions are able to 
recognize ligands on targets as divergent as eukaryotic apoptotic cells and 
prokaryotic bacteria. 
6.3 The PGRPs 
The PGRPs are a famous class of bacterial recognition proteins (Royet & Dziarski 
2007; Dziarski & Gupta 2006). The PGRP genes form clusters in the genome and 
are conserved throughout evolution from molluscs to mammals. In Drosophila there 
are 13 PGRPs, with some of them having multiple splice isoforms. There are short 
(S) and long (L) forms, and secreted and transmembrane PGRPs, but all share a 
peptidoglycan recognition domain, and differences in this domain determine ligand 
specificity: the secreted PGRP-SA, -SD and GNBP1 all recognize the Lysin-type 
proteoglycan of Gram-positive bacteria, while the membrane-bound PGRP-LC 
recognizes DAP-type proteoglycan of Gram-negative bacteria. Interestingly, these 
receptors not only recognize different types of bacteria, but also activate different 
signaling pathways in the cells, leading to the expression of antimicrobial peptides 
specific for a certain pathogen. In this way PGRP-SA activates the Toll pathway, 
leading to expression of Drosomycin, which specifically kills Gram-positive bacteria 
(Gobert et al. 2003), yeast and fungi, while PGRP-LC activates the Imd pathway, 
which leads to the transcription of Diptericin bactericidal to E. coli and other Gram-
negative bacteria (Gottar et al. 2002; Choe et al. 2002). In addition to its immune 
signaling function, PGRP-LC has also been identified as a phagocytosis receptor for 
Gram-negative E. coli on S2 cells: knock down leads to a significant reduction in E. 
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coli engulfment (Rämet et al. 2002). To further investigate the possibility that PGRPs 
might have functions in phagocytosis, we tested nine members of the PGRP family 
in our S2 screen (figure 14, p. 45; figure 15, p. 50). While we confirmed known 
functions for pgrp-sa and –lc, we were very surprised to find that they also seem to 
be required for the other bacterial type as well: pgrp-sa was also necessary for 
Gram-negative engulfment, and pgrp-lc for Gram-positive engulfment. Moreover, 
knockdown of both genes also seemed to affect apoptotic cell uptake in the cell-
based assay (figure 10, p. 36; figure 14, p. 45). To see whether these intriguing 
findings held true in vivo, we tested null mutants of both genes, totem (pgrp-lc -/-) 
and semmelweiss (seml, pgrp-sa -/-) in our embryonic apoptotic clearance assay as 
well as in the adult infection assays with E. coli and S. aureus. As expected, seml 
dies much faster from S. aureus infection than control flies, and totem flies are 
susceptible to E. coli infection. However, removal of pgrp-lc not only increases the 
flies’ susceptibility to E. coli, but also to S. aureus, and vice versa: pgrp-sa flies die 
significantly faster from E. coli as well, demonstrating that each of these factors are 
required for both Gram-negative and Gram-positive bacteria, which is in line with a 
recent finding coming to similar conclusions (S. Meister et al. 2009, figures 19, 20, 
p. 67, 68). While it is unexpected but not entirely surprising that PGRPs can be 
cross-specific for different types of peptidoglycan and therefore promote engulfment 
of different types of bacteria, we were surprised to see that both genes showed 
phenotypes in the apoptotic cell assay (figure 14, p. 45). For in vivo testing we 
needed to know whether these genes were expressed in the embryo. pgrp-sa is 
expressed in S2 cells, which are derived from embryonic macrophages, but 
according to three different expression profiles of S2 cells available to us, pgrp-lc is 
not. However, a paper investigating pgrp-lc function using RT-PCR shows that this 
gene is expressed and can be knocked down by specific RNAi (Rämet et al. 2002, 
table 2, p. 29). Also high throughput expression data (Flybase) show that both 
genes are expressed in the embryo, therefore we presumed that both genes are 
expressed and proceeded to test the null mutants in the apoptotic cell assay in vivo. 
pgrp-sa failed to show any significant effect. In contrast, pgrp-lc embryos displayed a 
twofold increase of apoptotic material in the Drosophila embryo, which shows that 
pgrp-lc is also required for phagocytosis of apoptotic cells, confirming the cell-based 
result (figure 18, p. 65). This finding is remarkable because it shows that apoptotic 
cells and bacteria must share surface determinants. More specifically, an apoptotic 
cell seems to expose ligands similar to bacterial peptidoglycan on its surface, leading 
to ligation by PGRP-LC on macrophages and subsequent engulfment of the corpse. 
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Here we demonstrate for the first time that a peptidoglycan recognition molecule can 
play a role in the recognition and phagocytosis of apoptotic cells.  
Taken together, we were able to identify many novel players in the engulfment 
process. We found novel factors in glial phagocytosis of apoptotic cells in the 
Drosophila embryo including bridging molecules, surface receptors and intracellular 
factors. We also found new factors required for phagocytosis of bacteria, which are 
necessary for the survival of an infection in the adult fly. Surprisingly, many of the 
factors showed cross-specificity and were also required for apoptotic cell 
phagocytosis by macrophages in embryonic development. Conversely, some of the 
apoptotic cell receptors also were cross-specific for bacteria and required for 















7.1 Screening for phagocytosis factors in S2 cells 
In order to shed more light on the developmentally and immunologically crucial 
process of phagocytosis, we performed a medium throughput candidate RNAi 
screen in Drosophila S2 cells, followed by in vivo validation using transgenic RNAi 
and mutant flies. Cell-based RNAi screens have been used extensively in Drosophila 
to investigate a multitude of cellular processes including growth and viability, 
signaling, cell shape, cell division and various other cellular and immune functions 
including phagocytosis (Cronin et al. 2009; Stroschein-Stevenson et al. 2006; Philips 
et al. 2005; Agaisse et al. 2005; Gwack et al. 2006; Hao et al. 2008; Dobbelaere et 
al. 2008; Nybakken et al. 2005; Guo et al. 2008).  While the first generation of RNAi 
libraries produced large numbers of OTE leading to high false positive rates, the next 
generation libraries, like the one used in this screen (HD2, kindly provided by 
Michael Boutros) were optimized in that regard, which significantly increased RNAi 
specificity and validity of results (Mohr et al. 2010; Boutros & Ahringer 2008; Horn et 
al. 2010; Seinen et al. 2011). Still, overlap between screens remained small, which is 
attributable to the differences in the techniques and protocols employed, stressing 
the importance of secondary screening. We therefore, according to current practice 
and in a first step to exclude false positives, designed secondary non-overlapping 
dsRNAs for 19% of our candidates to assess the OTE in our assays. Less than a 
fifth of the secondaries displayed discrepant results, which is on the lower end of 
what was to be expected from the literature, where discrepancies in secondary 
RNAs ranged from 15% to 84% (Chew et al. 2009; T. Liu et al. 2009; Wendler et al. 
2010, Hao et al. 2008; Sathyanarayanan et al. 2008, Guo et al. 2008).  A large 
majority of the RNAs used were specific for their target genes. 
When we look at results from other screens in comparison to ours, it first of all 
should it be noted that overlap between those screens is already small, with few hits 
being found in all or even multiple screens, and for the few genes that are found in 
more than one screen, a large majority has significantly different effect strengths. 
Where do these discrepancies come from? When we compare the protocols used to 
conduct those RNAi phagocytosis screens, there are many differences between all 
studies in all relevant parameters – numbers of cells transfected, amount of dsRNA 




out. Collectively these methodological differences are likely to be the reason for the 
small overlap between screens. We optimized our protocol for all of the above 
parameters to achieve a maximum differential in phagocytosis between positive and 
negative control. Even though individual effect strengths were often significantly 
different between our results and published data, we still were able to make the 
same binary calls – involved or not involved - for most of the genes previously tested 
(24/38 tests = 63% consistency). In summary, our secondary testing and 
comparisons with other studies raised confidence that we could use hits from this 
primary screen for further testing. 
7.2 Drosophila – a suitable in vivo model to study phagocytosis  
To really assess a gene’s function in a given process, it is however desirable to 
leave the milieu of cultured cells behind, which is very specific and highly susceptible 
to environmental changes, and proceed to in vivo testing. Genetic invertebrate 
models are useful for in vivo studies because of their short generation time, their 
relatively small size, simpler body plan and the genetic tools available. The two main 
invertebrate models are C. elegans and D. melanogaster, and both have been 
successful models for phagocytosis studies. In comparison to C. elegans, the linked 
processes of developmental apoptosis and phagocytosis have become much more 
complex in fly. While cell death is predetermined in the few cells that die during worm 
development, death during fly development occurs mostly stochastically and in large 
waves (Rogulja-Ortmann et al. 2007; Lettre & Hengartner 2006). Neighboring cells 
are sufficient to clear the occasional apoptotic cell in C. elegans, but Drosophila has 
specialized cells performing the increased task, namely glia in the nervous system 
and macrophages everywhere else. In contrast to C. elegans, which seems to rely 
mostly on humoral immunity, Drosophila also has an immune system very similar to 
the innate arm of vertebrate immunity, and professional phagocytes are well 
equipped to recognize and engulf dangerous invaders as well as initiate signaling 
cascades, which lead to a systemic immune response (Engelmann & Pujol 2010; 
Brennan & Anderson 2004). This professionalization of phagocytes is facilitated by a 
molecular diversification: while C. elegans only has the engulfment receptor ced-1, 
Drosophila possesses a whole gene family of related proteins, the NIMs, that seem 
to be involved in different types of phagocytosis: the ced-1 homolog drpr and simu 
are engulfment receptors for apoptotic cells, and NIMC1 is required for bacterial 




members of the NIM family. nimA is required for apoptotic clearance in the embryo, 
and nimC2 for S. aureus phagocytosis in the adult fly, thereby firmly establishing the 
NIMs as a family of diverse phagocytosis receptors.  
Another gene family present in fly, but not worm, are the PGRPs. These genes have 
been shown to play crucial roles in Drosophila immunity, because different members 
are specific for certain types of infections and not only promote engulfment of the 
respective pathogens, but trigger signaling cascades leading to the expression of 
pathogen-specific AMPs (Royet & Dziarski 2007). In the present study we revisited 
some of the players and surprisingly found that pgrp-lc, which had been known for 
initiating immune signaling against an E. coli infection, is in fact also required for 
apoptotic clearance in the Drosophila embryo, thereby expanding its function as an 
immune receptor.  
Drosophila possesses not only diversified families of genes present in the worm, it 
also contains homologs to vertebrate phagocytosis factors. Vertebrate cd36 and 
megalin have been linked to apoptotic clearance and Drosophila has homologs of 
these genes, which are expressed in macrophages and glia. While the cd36 
homolog crq has already been shown to be required for apoptotic clearance by 
macrophages in the Drosophila embryo, we show here that an additional homolog, 
santa maria, is required for glial clearance of apoptotic cells. Also megalin, which 
promotes phagocytosis of apoptotic cells in vertebrate macrophages, is expressed in 
Drosophila glia and, as we show here, is necessary for engulfment. We examine 
some additional factors that have been shown to play a role in vertebrates and find 
ubiquitous factors like Annexin and Calreticulin, which have been involved in 
apoptotic clearance in vertebrates, to be highly expressed in Drosophila glia and also 
required for apoptotic clearance here, underlining the similarities between 
phagocytosis in the fly and in vertebrates.  
While the sophistication of the molecular repertoire of Drosophila innate immune 
cells, remiscent of vertebrate macrophages, is remarkable, the real immunological 
achievement in vertebrates is the adaptive immune system. Vertebrates somatically 
rearrange immune receptors producing an infinite number of recognition molecules 
able to recognize every possible pathogen. Invertebrates are believed to not possess 
such a system; however it has been shown that the cell adhesion molecule DSCAM 
is produced in thousands of different splice isoforms, which recognize Gram-




response to specific pathogens (Watson et al. 2005; Dong et al. 2006). Moreover, we 
found DSCAM to also have another function, namely apoptotic clearance in the 
developing embryo. The diversity of DSCAM isoforms and the NIM and PGRP 
families place the Drosophila immune system and its phagocytes in between the 
worm and vertebrate models and make it an excellent model to study phagocytosis 
and immune functions. 
7.2.1 Dissecting phagocytosis in vivo 
To check whether our cell-based results track in vivo, we selected a subset of genes 
from the primary screen that were of particular interest to us (18 genes = 21% of all 
genes tested), on the basis that they were either highly expressed in glia, which is 
our primary focus, or showed new or unexpected food preferences. Many of these 
genes had been described in contexts other than phagocytosis, or had even been 
implicated in phagocytosis, but only of one specific food type, and we wanted to test 
its involvement in other types of phagocytosis. For four out of the 18 genes we were 
able to use available null mutants for our in vivo testing, for the others we used 
transgenic RNAi lines, which we expressed in macrophages or glia. We picked not 
only receptors, but chose genes to go along a longitudinal axis through the cell, from 
secreted and transmembrane receptors to the core machinery with signaling and 
vesicle traffic factors. We had seen that some receptors, previously claimed to be 
specific for apoptotic cells or a certain bacterial type, in fact seemed to be required 
for other types of food as well, based on our cell-based results. These intriguing 
findings led us to also cross-compare in vivo the different food types and not only 
focus on developmental clearance of corpses, but also investigate immunological 
clearance of pathogens. Therefore we tested all candidates in three previously 
established in vivo assays: apoptotic clearance in the embryo, and infection of the 
adult fly with E. coli or S. aureus. Even though phagocytosis of endogenous dying 
cells and of invaders is accomplished by the same cells and arguably using the 
same mechanisms, no systematic comparison between corpse and bacterial eating 
has been carried out to date; the fields of developmental genetics and immunology 
seem to not touch and our in vitro and in vivo comparison of these different yet 
similar processes is the first of its kind. 
7.2.2 In vitro results track in vivo 
Out of the 40 in vivo assays performed, a vast majority (93%) were congruent with 




culture flask compared to a whole fly. Because we were mostly working with RNAi, 
some of our results could be false positives or false negatives. We used in vitro and 
also largely in vivo RNAi to knock down gene function, thereby creating hypomorphs. 
The obtained reduction in gene expression may not be sufficient leading to false 
negatives. In contrast, RNAi, despite optimizations in RNAi design, is known to have 
OTE, which could knock down additional genes thereby creating false positives. 
However, our combined approach of cell-based and in vivo testing alleviates these 
issues because the cell-based and in vivo data provide excellent controls for each 
other. Effects observed in both systems, which are fundamentally different from each 
other (cell line vs. whole animal, transfected vs. transgenic RNAi, different dsRNA 
sequences), cumulatively raise confidence that an observed phenotype is significant. 
Also the overall satisfactory consistency between cell-based and in vivo data shows 
that our approach proves valid to identify new phagocytosis factors.  
It was particularly interesting to see that the apoptotic assay tracked exceptionally 
well in vivo (17 out of 19 genes tested), even though for some genes we tested 
macrophages in vitro and glia in vivo, corroborating the similarities between these 
cell types. There are two cases in the apoptotic cell assay where in vitro and in vivo 
did not match up: 1. pgrp-sa, were we saw an in vitro, but not an in vivo effect using 
a null mutant, which is potentially due to compensatory mechanisms in vivo; 2. For 
skittles, a PI3P kinase, we observed an effect in cells but not using transgenic RNAi 
in vivo, which could be explained either by an OTE in cells or insufficient RNAi knock 
down in vivo. Our S. aureus assays were similarly consistent with the cell-based 
results; here only one gene was discrepant. The biggest issue in reproducibility of 
cell-based results posed the E. coli assay. In contrast to S. aureus, E. coli is not 
pathogenic to wild type flies. Only few genes have been described to have any effect 
on the flies’ susceptibility to E. coli infection, and all of them are components of the 
IMD signaling pathway leading to expression of antibacterial peptides (Pal & Louisa 
P Wu 2009). Consequently, when we infect pgrp-lc – the Imd pathway receptor – 
flies with E. coli, half of the cohort is dead after two days. However, when we infect 
flies where pgrp-lc has been knocked down in macrophages using transgenic RNAi, 
we see no phenotypes. Similarly, when we tested our candidates, we saw effects for 
the null mutants, but not for any of the RNAi lines, suggesting that E. coli’s low 
pathogenicity combined with insufficient gene knock downs failed to reduce protein 
amounts to phenocritical levels. Another possible explanation, especially for the 
genes upregulated in glia, would be that these genes are not (highly) expressed and 




used in the literature to test different genes’ involvement in Gram-negative infections, 
there has not been a report so far about RNAi of any gene reducing Drosophila’s 
survival to an E. coli infection (Bischoff et al. 2006; Kambris et al. 2006; Sebastien 
Pili-Floury et al. 2004; Zaidman-Rémy et al. 2006). For two secreted genes, namely 
the thioester-containing complement genes tep2 and mcr, we saw an effect in vitro, 
but not in vivo. While this could be also attributed to the aforementioned issues, this 
is consistent with the literature, suggesting these genes play a more important role in 
embryonic macrophages than in adult ones. Because of the weakness of transgenic 
RNAi in E. coli infection we only included the results obtained from infecting null 
mutants with E. coli in our analysis. For the four genes for which we had null mutants 
available, we were able to reproduce the cell-based results in vivo, thereby 
identifying new players in Gram-negative phagocytosis. 
7.2.3 In vivo results track with literature 
Most of our candidates were not entirely novel genes without any known function, 
but rather factors that had been implicated more or less well in one or another 
functional process, some in phagocytosis of a different food type. Therefore it was an 
important proof of principle to be able to recover known functions with our 
methodology. When we compare our in vivo findings with those from other studies, 
we find that all of our observations are consistent with published results. This, in 
contrast to the lower overlap between cell-based screens, underlines the importance 
of in vivo testing, which is apparently highly robust across different research groups 
and protocols. 
7.3 Novel glial players in corpse removal 
Our screen was initially motivated to elucidate the relatively recent discovery of 
Drosophila glia as competent and almost professional cells that can efficiently 
remove dying neurons in the developing CNS; in simu we found the second factor 
ever identified that is required for glial corpse clearance (Kurant et al. 2008). The 
expression profiling of embryonic glia performed in our lab, which also produced 
simu, showed that multiple putative phagocytosis genes were ranking high in the list, 
supporting the idea of glia as semi-professional phagocytes, and providing us with 
interesting candidates to further explore glial function.  
calreticulin is an example of a ubiquitously expressed chaperone. The function of its 




playing a role in apoptotic clearance in mouse macrophages (Michalak et al. 2009; 
Gardai et al. 2005; Vandivier et al. 2002; Müller-Taubenberger et al. 2001). Our main 
goal was not comparing macrophages with glia, but exploring glial function. Because 
crc is highly upregulated in glia we decided to see whether it plays any role in corpse 
removal by glia in the embryonic CNS. Indeed we saw a requirement for crc in glia 
for clearance of apoptotic cells, which is in line with previous reports that CRC can 
act as a (co-)receptor for apoptotic cells in vertebrates (Vandivier et al. 2002). 
Another conserved player highly expressed in glia is annexinIX, removal of which 
has been shown to be involved in apoptotic clearance in worm, and inflammation 
and autoimmune disease in mouse (Arur et al. 2003; Y. H. Yang et al. 2004; Hannon 
et al. 2003). ANNIX is a secreted molecule and acts as an opsonin by recognizing 
newly exposed PS on the apoptotic surface, and we observe that also in Drosophila, 
knock down of annIX leads to impairment of apoptotic clearance, probably because 
the apoptotic cells lose an important “eat-me” signal. This hypothesis is corroborated 
by the fact that injection of fluorescent recombinant ANNV into the Drosophila 
embryo specifically labels early apoptotic cells in the nervous system (Kurant et al. 
2008). It seems that glia produce, secrete and eventually recognize apoptotic cells 
using ANNIX; the last step however, the ligation of ANNIX-opsonized apoptotic cells 
to the glia, requires a yet to be identified receptor on the glial surface. In vertebrates 
it has been suggested that ANN coclusters with PS on the apoptotic cell surface, 
thereby facilitating binding of the complex by a PS-receptor on the phagocyte (Arur 
et al. 2003). However the identified PS-receptor turned out to be a transcription 
factor, mystifying its role in the process (Cui et al. 2004; Mitchell et al. 2006; 
Williamson & Schlegel 2004).  
CD36 and LDLR family members are classical scavenger receptors with broad 
ligand specificity and have been known to be expressed in macrophages, where they 
facilitate disposal of hydrophobic material including lipids and lipoproteins from body 
fluids. Here we report involvement of two Drosophila homologs belonging to these 
families in glial clearance of apoptotic cells. 
The CD36 family of lipoprotein-binding receptors is evolutionarily conserved and is 
required for lipoprotein transport and uptake of cholesterol and lipids in vertebrates 
(Collot-Teixeira et al. 2007). CD36 has been associated with a variety of human 
disorders including insulin resistance, dyslipidemia, and atherosclerosis. Intriguingly, 
CD36 and its homologs have been implicated in various types of phagocytosis in 




highly conserved, and the CD36 homolog crq in Drosophila has also been shown to 
be required for phagocytosis of apoptotic cells, in this case by macrophages in the 
developing embryo (Franc, Heitzler, et al. 1999). In the glial expression profiling from 
our lab a gene very similar to crq was shown to be highly expressed in embryonic 
glia: santa-maria, a gene that had been previously involved in fatty acid uptake by 
neurons and glia in the adult eye (Wang et al. 2007). Intriguingly, we found santa 
maria to be required for glial removal of corpses in the embryonic CNS. How does 
santa maria recognize apoptotic cells in the CNS? It has been shown in vertebrate 
cell-culture experiments that vesicles containing oxidized (but not nonoxidized) PS 
inhibit phagocytosis of apoptotic cells in a CD36-dependent manner (Greenberg et 
al. 2006). Although little is known about the ligands promoting apoptotic cell 
phagocytosis in Drosophila, we have previously shown that PS is likely to play a role 
here, as PS-binding Annexin labels apoptotic cells in the embryonic CNS, therefore it 
is possible that SANTA MARIA’s ligand on apoptotic cells is oxPS (Kurant et al. 
2008).  
Another putatively lipid-binding scavenger receptor is megalin. megalin is a large 
multiligand receptor and member of the LDL receptor family. It is widely expressed in 
epithelial tissues and mediates endocytosis of a variety of ligands from the apical 
surface (Christensen & Willnow 1999; Moestrup & Verroust 2001). In Drosophila, 
megalin has recently been shown to be required for internalization of the pigment 
protein yellow, thereby regulating cuticle pigmentation in the adult wing (Riedel et al. 
2011). megalin is highly expressed in embryonic glia, according to our expression 
profiling, and interestingly shares some sequence similarity in its intracellular portion 
to drpr. As we show here, megalin is necessary for glial corpse clearance. Members 
of the vertebrate LDLR family have also previously been implicated in phagocytosis: 
LDLR in phagocytosis of aggregated oxidized LDL, and LDLR related protein (LRP) 
in phagocytosis of aggregated LDL as well as phagocytosis of apoptotic cells. 
Members of the LDLR family have wide ligand specificity and recognize various 
lipids and lipoproteins. Of particular interest are oxLDL and PS, which are present on 
apoptotic cells. It has been shown that blocking both lipids inhibits phagocytosis of 
apoptotic cells, suggesting that these are at least some of the ligands recognized by 
Drosophila glia on apoptotic cells (Sambrano & Steinberg 1995).  
We found not only that putative apoptotic cell receptors are required for glial 
phagocytic function, but curiously a protease normally required for ECM degradation 




implicated in a variety of tissue remodeling processes including bone formation and 
remodeling, mammary development, blood vessel formation, inflammation and 
wound healing (Page-McCaw et al. 2007). In Drosophila it has been shown that null 
mutants for either of the two fly mmp’s leads to aberrant axon defasciculation in the 
embryo, perturbing normal nervous system development, as well as causing 
abnormal tracheal development (C. M. Miller et al. 2008; Glasheen et al. 2010; 
Yasunaga et al. 2010). These functions are accomplished by proteolytic cleavage of 
a variety of substrates including ECM components, cell-surface receptors and cyto- 
and chemokines, thereby changing tissue composition and properties. The only hint 
at a function in phagocytosis stems from reports stating that a mouse homolog of 
mmp1, Mt-1 MMP, is implicated in degrading collagen fibrils to prepare them for 
phagocytic uptake by macrophages, a process relevant to wound healing, 
inflammatory diseases, and cancer cell invasion (H. Lee et al. 2007). mmp1 was 
highly ranked in the glial expression profile and our in vivo knockdown in glia 
significantly reduces glial phagocytosis of apoptotic cells in the developing CNS, for 
the first time establishing a member of this group of proteases in the engulfment 
process. How MMP1 assists glia in engulfing apoptotic cells remains to be 
elucidated; based on the many possible functional mechanisms, it is conceivable that 
secreted MMP1 shears a “don’t eat me signal” from the apoptotic cell, or, reversely, 
activates an “eat-me” or “find-me” signal. Another explanation could be that it simply 
helps glia in probing their surroundings by shearing away matrix components in the 
immediate vicinity of the phagocytosing glia.  
As our goal was not only want to find new surface receptors specific for apoptotic 
cells, which, given the systematically unspecific nature of many receptors, turns out 
to be challenging, downstream effectors from vesicle trafficking were also included. 
We had assumed a broad and unspecific requirement for these factors in any type of 
phagocytosis, but at least for the two candidates picked for in vivo validation, 
obtained the opposite result. SYB and Cyp4g15, loosely appointed to vesicle traffic 
based on their subcellular localizations – exosomes for SYB and ER for the 
Cytochrome P450 family member Cyp4g15, both showed effects exclusively in 
apoptotic clearance. syb also showed a requirement for both types of bacterial 
phagocytosis in our cell-based assays, but not in vivo. This discrepancy might be 
explained by the nature of the syb function, which had been elucidated in mouse cell 
culture studies. syb is a membrane fusion protein localized on late endosomes, and 
when phagocytes extend pseudopods to enwrap their target, syb is required for rapid 




endosomes (Braun et al. 2004). It seems logical that syb requirement would depend 
on the target particle’s size. In the cell-culture assay, bacteria-to-phagocyte-ratios 
are high in order to achieve homogenous coverage of cells with food. Therefore 
engulfment of large apoptotic cells or chunks of (dead) bacteria in vitro requires more 
membrane delivered to the phagocytic cup than engulfment of small live bacteria that 
are solitary, which is more likely to be the case in vivo. Another explanation is of 
course a differential requirement for syb in macrophages. We knocked down syb in 
macrophages, and not in glia for the adult infection assays. Macrophages might be 
able compensate for lack of syb, while glia could not. 
It seems that glia are fully equipped for the task of apoptotic clearance in a variety of 
ways that this study helped to unveil. Glia express a multitude of specific and 
unspecific apoptosis receptors on their surface and even secrete MMP1 and 
opsonins into the extracellular space to trace nascent apoptotic cells. They 
upregulate vesicle traffic constituents in order to be prepared to quickly engulf and 
clear away big corpses. Drosophila glia, even though stationary and not motile like 
macrophages, have a large battery of tools that allow them to detect, engulf and 
degrade apoptotic cells as efficiently as the real professionals – macrophages, 
calling for glia to be classified as quasi-professional phagocytes. 
7.4 Cross-specificity 
One of the key findings in our screen was that many genes are not only required for 
phagocytosis of one type of food, but actually for multiple food types. This 
systematically reveals for the first time in Drosophila that there is overlap between 
apoptotic and bacterial clearance. In fact, in the cell-based screen only 20% of genes 
were specific to one food type, and most of those for apoptotic cells (figure 16, p. 
54). Even though we tested only a relatively small set of genes, there is no inherent 
bias in the selection: of the genes chosen, seven had previously been implicated in 
corpse clearance, and eight in bacterial clearance. Interestingly, the cross-specificity 
is not highest for the two bacteria tested, but for apoptotic cells and one or even both 
types of bacteria. This is surprising, as foreign prokaryotic bacteria seem to be 
fundamentally different from self-derived apoptotic cells, yet apparently macrophage 
factors promoting phagocytosis do not distinguish that much between the food types 
presented. When we look at the in vivo results, this overlap in food specificity 
continues (figure 21, p. 84): macrophage receptors in particular are exceptionally 




recognize not just one specific food type, but two or even all three of the tested 
targets. Again, specificity is crossed not only between Gram-negative and Gram-
positive bacteria, but actually more often between bacteria and apoptotic cells (four 
genes).  
Which type of genes do the promiscuous factors belong to? SIMU and DRPR were 
the anchor points for phagocytosis research in our lab and led to extensive studies of 
their functions in apoptotic clearance in the developing embryo. Both genes act in 
conjunction in the same pathway for corpse removal, and knockout of either of them 
leads to an accumulation of apoptotic material in the embryo (Kurant et al. 2008). 
Recently both genes have been identified as members of a protein family of related 
genes, the NIM family. Some members of the NIMs are required for bacterial 
phagocytosis: nimC1 for S. aureus (Kurucz et al. 2007) and eater for both S. aureus 
and E. coli (Kocks et al. 2005). Also drpr was recently shown to play a role in 
clearance of E. coli and S. aureus in addition to its known role in corpse clearance 
















































































Draper + + + + + + + + + + +
Simu + + + + + + +
NimA + + - - -
NimC1 - - - + + + +
NimC2 - - - + +
PGRPs
PGRP-LC + + + + + + + - + +
PGRP-SA + - + + + + + + +
Other surface proteins
Megalin + + + - -
Santa maria + + + - -
Calreticulin + - + - - -
Annexin IX + + + + + - -
Bacterial recognition
Mcr + + + + - + - +
TEP2 + + + + - - - - -
DSCAM + + + - -
ECM MMP1 + + + - -
PIPs Skittles + - - - -
Vesicle trafficking
Synaptobrevin + + + + -
Cy4p15 + + - - -
gene required for 1 type of food
gene required for 2 types of food

















Figure 21: Cross-specificity of phagocytosis genes tested in vivo. 
A Shown is presence (+) or absence (-) of an effect on phagocytosis of apoptotic 
cells, E. coli and S. aureus in the cell-based in vitro screen as well as in vivo. Many 
genes are required for phagocytosis of multiple food types. Genes required for 1 type 
of food are in red, for 2 types of food in blue and for 3 types of food in green boxes. 
Shaded in grey are results that are discrepant between cell-based and in vivo testing 
in our hands. B Pie chart displaying gene proportions affecting single food types or 
combinations of foods in the in vivo assays. Displayed are only genes that have 
been validated in vivo. The reds show proportions of factors specific to only one type 
of food. Light green: genes affecting 2 types of food. Bright green, 3 genes showed 
phenotypes in all three in vivo assays. 
 
Still, we were very surprised to find drpr and simu to be required not only for 
apoptotic clearance, nor for just one but for both types of bacterial eating and 
survival of Gram- positive and Gram-negative infections, turning these genes from 
specific apoptotic cell receptors to general phagocytosis receptors with a broad 
target specificity. Our lab has previously shown that SIMU’s function does not 
depend on the presence of its transmembrane domain, but rather on the N-terminal 
EMI domain, which is likely to specifically interact and recognize molecular patterns 
on the target surface (Kurant et al. 2008). It will be interesting to see what the EMI-
recognized patterns on apoptotic cells and bacteria are, and how they both can elicit 
SIMU-mediated engulfment. 
While simu and drpr do not seem to distinguish between apoptotic cells, Gram-
negative and Gram-positive bacteria, the NIM family also seems to contain members 
that are specific for certain food types. NIMC1 had already been shown to only 
recognize S. aureus, which we confirm with our in vitro and novel in vivo results, and 
additionally find that the closely related nimC2 also shows the same phenotype. 
nimC1 and nimC2 are structurally similar and have a similar length compared to the 
other nimrods, which are either much longer or shorter; nimC1 has 16, and nimC2 10 
NIM-repeats and both are transmembrane molecules. Despite their similarities they 
apparently cannot substitute for each other, as both are individually required to fight 
an aggressive S. aureus infection. Even though much more intensely and longer 
studied, only few phagocytosis receptors are known in the Drosophila immune 
system – a stark contrast to the plethora of identified vertebrate factors (admittedly 




(Stuart & Ezekowitz 2008). Very few studies (Kocks et al. 2005; Gottar et al. 2002; 
Choe et al. 2002; Bou Aoun et al. 2011; Nehme et al. 2011) actually test their factors 
in adult fly infection models questioning the relevance of a given factor for fly 
immunity. While in vivo assays like thoracal injection of fluorescent bacteria into flies 
(Cuttell et al. 2008) might be a more direct measure of phagocytosis, monitoring fly 
survival gives an exact read out of the impact a gene has on the immunity or 
susceptibility to an infection. Therefore, our confirmation of nimC1 and discovery of 
nimC2, but also the identification of the less specific simu, drpr and mcr as novel S. 
aureus phagocytosis receptors in vivo and the fact that these genes are required to 
longer withstand an infection in the adult fly provide an important increase of 
knowledge for the field of fly immunity.  
While drpr turned out to be quite a promiscuous player, the most closely related NIM 
is not: we find nimA to be exclusively required for phagocytosis of apoptotic cells. It 
remains to be tested whether nimA functions in the same pathway as simu and drpr 
and acts as an interchangeable drpr homolog, or whether it functions independently 
of this pathway. Its exact function in phagocytosis remains to be elucidated, but its 
molecular structure, which is so similar to DRPR suggests that NIMA is also a 
recognition receptor for apoptotic cells. nimA, like drpr, has an N-terminal EMI-
domain followed by exactly one NIM repeat and two (instead of 15) EGF-like repeats 
making it the only other family member to contain EGF-like repeats. Moreover, nimA 
and drpr are the only two family members to contain a large intracellular domain, 
which in the case of DRPR has been shown to promote signaling though activation 
of the non-receptor tyrosine kinase SHARK by binding its intracellular src-
phosphorylation motif (Ziegenfuss et al. 2008).  nimA’s exclusivity for embryonic 
corpse clearance is not due to a lack of expression in the adult fly, as RT-PCR 
analyses show the gene to be expressed throughout all developmental stages and in 
adulthood. Therefore it will be interesting to study what it is that allows DRPR, but 
not NIMA, to recognize bacteria in addition to apoptotic cells.  
Another protein class of phagocytosis factors are the PGRPs, and for the first time 
we report that the E. coli receptor PGRP-LC, arguably the most studied gene in the 
whole family, is not only not specific for E. coli, which had been already suggested 
by one study (S. Meister et al. 2009), but not even specific to bacteria, as it is 
strongly required for apoptotic clearance in the Drosophila embryo. This is a slightly 
different case than for simu and drpr, because PGRP-LC is thought to activate the 




Drosophila’s humoral arm of defense, namely the expression of antibacterial 
peptides, which are released into the hemolymph and specifically destroy Gram-
negative bacteria (Royet & Dziarski 2007). Phagocytosis of apoptotic cells, however, 
is supposed to be an immunologically silent event: in higher organisms, which are in 
danger of acquiring auto-immune diseases due to adaptive immunity, macrophages, 
after engulfing an apoptotic cell, even release anti-inflammatory cytokines to avoid 
inflammation (Krysko et al. 2006). In Drosophila we at least know that the IMD 
pathway is not activated unless there is a real threat – a Gram-negative infection – 
which leads us to the question: how can the same receptor on the one hand promote 
proinflammatory signaling when recognizing a specific bacteria, and on the other 
hand facilitate only silent engulfment, when faced with a dying cell? One answer 
could be that Drosophila relies on combinatorial input with other receptors, similar to 
the successful vertebrate model, where recognition of pathogen-associated 
molecular patterns is outsourced to the toll-like receptors, a non-phagocytosing 
receptor class exclusively dedicated to pathogen recognition (Takeda et al. 2003). 
According to this model PGRP-LC promotes engulfment in any case, but activates 
immune signaling only in conjunction with a putative second E. coli receptor, which 
cannot facilitate phagocytosis itself.  
The third family of putative phagocytosis receptors, members of which we included in 
our screen, are the TEPs. This gene family is highly conserved in evolution and its 
function is to opsonize their bacterial targets for phagocytosis or, at least in 
vertebrates, instant lysis (Philippe 2004; Blandin & Levashina 2004). Drosophila has 
five functional tep genes, four of which we included in our screen and two of which 
were tested in vivo. mcr as well as tep2 were identified in a S2 cell screen as 
bacterial receptors for both S. aureus and E. coli, and we recover these known 
functions in our S2 screen (Stroschein-Stevenson et al. 2006). A recent study tested 
tep involvement in survival of different Gram-positive and -negative infections as well 
as phagocytosis in vivo using tep mutants, in which gene expression is strongly 
reduced due to P-element insertions at the transcription start sites or, for tep1, 
ubiquitously expressed transgenic RNAi  (Bou Aoun et al. 2011; Thibault et al. 2004). 
Surprisingly, the authors could not find any requirement for any of the genes in any 
infection, suggesting that these genes can substitute for each other in vivo. However, 
even double and triple mutants did not succumb faster to infections than control flies. 
The one gene not tested in this study was mcr, because the mutant is larval lethal. 
mcr was identified in a S2 screen for fungal phagocytosis, but in our S2 screen we 




finding and show that knockdown of mcr in macrophages reduces fly survival of S. 
aureus infection, thereby for the first time revealing a function for any of the TEP 
family members in vivo in Drosophila. 
7.5 Apoptotic cell opsonins 
Both tep2 and mcr were unexpectedly required for apoptotic cell phagocytosis 
according to our cell-based screen, and these results were confirmed in vivo, where 
both genes were required for corpse clearance in the embryo by macrophages. TEP 
involvement in apoptotic clearance is interesting not only from the standpoint of 
cross-specificity, but also in that this, along with the earlier described glial annIX, is 
the first time secreted factors are being implicated in apoptotic cell clearance in 
Drosophila. The mechanism of opsonization in general is the release of opsonins 
into the body fluid, recognition of and attachment to molecular patterns – classically, 
specific bacterial sugar residues – on target particles (opsonization itself), and 
recognition of these closely clustered surface “labels” by specific receptors on 
phagocytes. The concept of opsonins acting not only on pathogens, but also on 
apoptotic cells is not new; a number of so-called bridging molecules recognizing 
altered plasma membrane lipids and proteins have been described mainly in 
vertebrates, but also C. elegans, the most prominent being AnnexinI/V, which 
recognizes freshly exposed phosphatidylserine on apoptotic cells. Interestingly, most 
factors that showed apoptotic clearance phenotypes in vivo in vertebrates were not 
macrophage receptors, but such serum opsonins/ bridging molecules (Y. Wu et al. 
2006). These factors are transported by the blood and lymph through all body 
tissues and therefore act as sensors of apoptotic events, and when those bridging 
molecules recognize a corpse, phagocytes are recruited for engulfment. It seems 
that this early warning system is particularly sensitive to perturbations, and single 
gene knockouts in mice already lead to severe autoimmune diseases. In Drosophila, 
however, such factors had not been described to date. While for the vertebrate 
complement proteins, the macrophage receptors have been identified (Philippe 
2004), it is not clear how bridging molecules are ligated to phagocytes, and also how 
TEP-opsonized apoptotic cells are recognized and engulfed by macrophages in 
Drosophila remains to be elucidated.  
Another secreted molecule we found to unexpectedly play a role in corpse clearance 
is DSCAM, an Immunoglobulin superfamily member that had been initially described 




isoforms that are generated by alternative splicing, these molecules are able to 
confer highly specific cell-cell adhesion through homophilic binding of identical 
receptor isoforms on different cells. The large number of possible isoforms gives 
cells distinct identities and thereby facilitates correct connectivity between neurons 
(Schmucker & B. Chen 2009). Recently it has been found that DSCAM is also 
expressed by hemocytes, which produce a similar variety of splice isoforms, but 
then, at least partially, secrete the immunoglobulins into the hemolymph. S2 cell 
phagocytosis of E. coli could be blocked by anti-DSCAM antibodies and dscam 
expression was shown to be necessary for E. coli phagocytosis by larval hemocytes; 
furthermore specific DSCAM isoforms were shown to bind E. coli (Watson et al. 
2005). Spectacularly, it has been found that in mosquitoes, hemocytes’ dscam 
expression is not random, but depends on the infection and that specific splice 
isoforms are upregulated in response to specific pathogens, reminiscent of clonal 
selection of antibodies – also immunoglobulins – and T-cell receptors during 
vertebrate adaptive immune responses (Dong et al. 2006). We included dscam in 
our screen based on the possibility of it being a phagocytosis receptor, and indeed 
observed a requirement for E. coli phagocytosis by S2 cells as had previously been 
described. Surprisingly, we also saw dscam involvement in apoptotic clearance in S2 
cells and were able to validate this phenotype in vivo, where it was required for 
corpse clearance in the embryo by macrophages. This finding suggests a completely 
novel role for this factor in addition to neuronal wiring and immunity. How DSCAM 
functions in recognition and uptake of corpses is unclear, but could be accomplished 
through a two-step process: secreted DSCAM isoforms recognize and opsonize 
apoptotic cells and then homophilically bind to other DSCAM molecules that 
remained transmembrane on the macrophage surface. Such a mechanism would be 
similar to the process described in vertebrates, where antibodies recognize oxidized 
lipids on apoptotic cell surfaces and subsequently promote macrophage engulfment 
through Fc-receptor ligation (Ogden & Elkon 2006; Hart et al. 2004). 
We present here for the first time a systematic study addressing various open 
questions in phagocytosis research: how do macrophages engulf dying cells during 
development? How do glia engulf dying neurons during development? What are 
secreted, surface or downstream factors required for phagocytosis? How do 
macrophages in the adult fly fight different bacterial infections? What are the 
overlaps between apoptotic and bacterial clearance? Our comprehensive cell-based 
and in vivo approach shed light on these topics and revealed many new players in 
this complex process that is crucial for organismal development and homeostasis. 
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8 Materials and Methods 
8.1 Cell culture and RNA bathing 
Schneider cells (S2) were maintained in Schneider’s Drosophila medium (BioSell) 
supplemented with 10% heat-inactivated FCS (Gibco BRL) and 1% penicillin/ 
streptomycin (Gibco BRL). For RNA bathing 0.4 x 106 cells/ well were plated in 
serum-free media in 96 well plates, 0.7 µg dsRNA was added, cells were incubated 
for 45 min and 2 volumes of full media were added. Phagocytosis assays were 
performed after 72 h.  
8.2 Phagocytosis assays 
RNAi treated S2 cells were fed different particles: carboxylated yellow-green beads 
(Polysciences), E. coli-AF488, S. aureus-AF488 (Invitrogen) or apoptotic cells. 
Apoptotic cells were generated by adding 75 µg/ ml etoposide to S2 cells for 16 h. 
Apoptotic cells were fluorescently labeled by incubation with 5 µl/ml DiI (Invitrogen) 
for 25 min at 37°C and washing twice with PBS. Beads, bacteria or apoptotic cells 
were added to S2 cells in 50 µl but at different concentrations reflecting different 
optimized eater:food ratios: 3-5 beads/ cell, ca. 15 bacteria/ cell and 2-3 apoptotic 
cells/ cell. Cells were spun down to synchronize the start of engulfment and 
incubated for 2 h (beads), 2 h (S. aureus), 2.5 h (E. coli) and 3.5 h (apoptotic cells). 
Extracellular beads and bacteria were quenched using TrypanBlue 1:2 (pH 5.5, 
Invitrogen). 
8.3 Flow cytometry analysis of phagocytosis  
FACS Calibur with CellQuest software (BD Biosciences) was used to acquire 5000 
S2 cells and record the parameters forward and side scatter, red or green 
fluorescence and time for each cell. Phagocytosis was assessed using FCS Express 
(De Novo Software) and calculating the product of percentage and fluorescence 
mean of positive cells, as has been described before (Rämet et al. 2002; Philips et 
al. 2005), see also figure 9A-C, p.  34. For apoptotic cells the fluorescence mean of 
the whole eater population was determined as a measure of the amount of engulfed 
corpses (figure 9D). Results were normalized to gfp RNA treated controls and 
experiments were repeated 3-7 times (technical and biological replicates). Means 
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were calculated and significance was assessed using calculating q-values and false 
discovery rate analyses. 
8.4 Fly strains 
The fly strains used in this study were obtained from the following sources: 
Table 4: Fly strains used in this study.  
 A miscellaneous sources, B VDRC lines 
A   
Genotype Source 
w; DD1; PGRP-SA  (seml) M. Ramet 
w; PGRP-LC∆5 (totem) M. Ramet 
drpr Δ5 M. Freeman 
simu E. Kurant 
w; P{UAS-dicer2, w[+]} VDRC 
repo-Gal4 V. Auld 
crq-Gal4 P. Martin; gift from H. Agaisse and N. Perrimon 
 
B used VDRC RNAi lines   
Gene Transformant ID RNAi library 
AnnexinIX 106867 KK 
Calreticulin 51272 GD 
Santa maria 33153 GD 
Cyp4g15 8034 GD 
DSCAM 108835 KK 
MEGALIN 105387 KK 
Mcr 100197 KK 
Mdr65 9019 GD 
MMP1 101505 KK 
NIMA 104204 KK 
NIMC1 105799 KK 
NimC2 36264 GD 
NimC2 3705 GD 
Skittles 101624 KK 
Synaptobrevin 102922 KK 
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TEP2 106997 KK 
8.5 dsRNA library 
DNA templates and dsRNAs for the 86 candidate genes were obtained from Michael 
Boutros, DKFZ, Heidelberg. Exact positions and sequences of probes can be viewed 
here: http://genomernai.de/GenomeRNAi/ 
Gene name Fly base ID RNA probe ID  Gene name Fly base ID RNA probe ID 
Annexin IX CG5730 BKN30217  NimB4 CG33115 BKN31092 
Arp66B CG7558 BKN22344  NimB5 CG16873  HFA 973165 
Calreticulin  CG9429 BKN21487  NIMC1 CG8942 BKN30957 
Cdc42 CG12530 BKN28698  NimC2 CG18146  BKN27282 
CG10702 CG10702 BKN23880  NimC3 CG16880  BKN32612 
CG7447 CG7447 BKN22763  NimC4 (SIMU) CG16876 BKN30227 
Coracle  CG11949 BKN29444  PGRP-LA CG32042 BKN31407 
CP-1 CG6692 BKN27765  PGRP-LC CG4432 BKN24423 
Crk CG1587 BKN28690  PGRP-LE CG8995 BKN25992 
Croquemort  CG4280 BKN23364  PGRP-LF CG4437 BKN22639 
Santa maria  CG12789 BKN23760  PGRP-SA CG11709 BKN27520 
Cyp4g15 CG11715 BKN25252  PGRP-SB1 CG9681 BKN24293 
dCED-12 CG5336 BKN22884  PGRP-SB2 CG9697 BKN32145 
dCED-6 CG11804 BKN22637  PGRP-SC1A CG14746  HFA 973177 
Dmoesin CG10701 BKN28480  PGRP-SD CG7496 BKN25597 
DRPR  CG2086 BKN28333  Pi3K59F  CG5373 BKN27602 
Dscam CG17800 BKN20392  Pi3K68D  CG11621 BKN27399 
dSR-CI CG4099 BKN23236  Pi3K92E  CG4141 BKN22357 
Dystroglycan CG18250 BKN20924  Psr CG5383 BKN27474 
EcR CG1765 BKN31288  PTEN CG5671 BKN29278 
EGFR CG10079 BKN20147  Puckered CG7850 BKN25001 
Eiger CG12919 BKN23624  Pvr CG8222 BKN21626 
Eip63E CG10579 BKN28615  Rac1 CG2248 BKN28456 
Fps85D CG8874 BKN22088  Rac2 CG8556 BKN30237 
Gartenzwerg CG8487 BKN20511  Rho1 CG8416 BKN28182 
Gliolectin CG6575 BKN30169  Sac1 CG9128 BKN20150 
Hem/ Kette CG5837 BKN20432  SCAR CG4636 BKN22532 
Hemese CG31770 BKN30432  Shark CG18247 BKN22750 
Hemomucin CG3373 BKN27462  Shibire  CG18102 BKN21495 
inflated CG9623 BKN28544  Short stop CG18076 BKN21543 
Jra CG2275 BKN20678  Skittles  CG9985 BKN24385 
MEGALIN CG34352 BKN20531  SRA-1 CG4931 BKN21483 
Malvolio CG3671 BKN28406  Syb CG12210 BKN33351 
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Mbc CG10379 BKN28072  TEP1 CG18096 BKN25880 
Mcr CG7586 BKN25702  TEP2 CG7052 BKN21154 
Mdr65 CG10181 BKN26133  TEP4 CG10363 BKN26228 
Mig-2-like CG5588 BKN31897  TIMP  CG6281 BKN28268 
MMP-1 CG4859 BKN28894  Trio CG18214 BKN28958 
myospheroid CG1560 BKN20614  Vav CG7893 BKN27749 
NIMA  CG31765 BKN25308  Vha14 CG8210 BKN22163 
NimB1 CG33119 BKN23336  W CG2759 BKN29569 
NimB2 CG31839 BKN26789  zCOP CG3948 BKN28399 
NimB3 CG34003 BKN41810  α-Adaptin CG4260 BKN20148 
 
For reamplification of dsRNAs from DNA templates in 96-well plates the standard 
Boutros Lab protocol was used: http://b110-
wiki.dkfz.de/signaling/wiki/display/rnaiwiki/Protocols+RNAi+library+generation 
Secondary RNAs were designed using the eRNAi tool from the Boutros Lab 
(http://www.dkfz.de/signaling/e-rnai3//). This algorithm avoids low-complexity regions 
in the target sequence for probe design and includes predictions regarding the 
specificity and efficiency of a probe allowing to estimate and avoid OTE. Probes 
were generated as described by Kennerdell & Carthew (1998). dsRNA probes were 
synthesized from PCR products of the respective cDNAs with T7 promoter 
sequences added on the 5’ and 3’ of the PCR primers. 
 
 
Table 5: Secondary dsRNA primers. 
T7 sequence was added 5’ of each primer 
Cdc42 fw TGCCCGAGATTACACACCAT 
Cdc42 rev CGAGCACTCCACGTACTTGAC 
Drpr fw GCGGTGGTGTGCGTACGCAAATAT 
Drpr rev GGCAACATGGTGGCAGTGGATT 
Dscam fw AGGAGAACCCGCCGTACT 
Dscam rev GTGCGCTTGATCGACAGACT 
Dscam fw TGCTGGAGACACTGAAGGAA 
Dscam rev AGGCTAGGCAAAGGATGAGTT 
Mdr65 fw GGTGTGCGCTATCGAGGTAT 
Mdr65 rev TCATCGGGATCATAGTAACGC 
Pi3K68D fw CCCATTGGTCTTCTGGAGTG 
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Pi3K68D rev CTCATCATCCCGCTCAGTTC 
Rac2 fw CGGGCCCAATTAATTCATAA 
Rac2 rev CACACACACACACATTCAAGC 
MEGALIN fw TATTGGCCACCAGTTAAGCG 
MEGALIN rev CACTTCCATTGCGCGTATAG 
Syb fw TTTTCCCATACTTCCGCCAC 
Syb rev ACCTTCTCCACGTTCACACG 
Gliolectin fw AGACCACAACAACAAAAGCAACCCCAG 
Gliolectin rev AGACCACTGTGTGTTTGTTTGTGGGCT 
Annexin IX fw AGACCACAACCAACAACAGGAGGATGC 
Annexin IX rev AGACCACCAGCTTTGCCGTTGAGTGTA 
PGRP-LC fw AGACCACCAACGAAGGAAGTCTGCTCC 
PGRP-LC rev AGACCACGATAGGGGTTAGGTGGGGAA 
Mcr fw AGACCACTATTACGCCAGGGTTTAATGGAAGT 
Mcr rev AGACCACGCTGGTTAATCTTCCACACTACAAT 
TEPII fw AGACCACCAGCCTGTTTTGGGTACCT 
TEPII rev AGACCACTTCTTCACCACAACCTGATAG 
MMP1 fw AGACCACCTTCTATCGCGGCTTTGAAC 
MMP1 rev AGACCACAACTTGCTGCCCTTGAAGAA 
Puckered fw AGACCACACCAACCACAAAGCGAAAAC 
Puckered rev AGACCACTAGCATTCGCGTTACACTGC 
GFP fw AGTGGAGAGGGTGAAGGTGA 
GFP rev AAAGGGCAGATTGTGTGGAC 
  
RT-PCR/ in situ primers: 
NIMA fw CCGGAGGTATCACCACAAAAATGC 
NIMA rev GGCATAGGCGTAAGGTGGGGTTTT 
NimB1 fw TCTACTGACGCTGGTGGCATTTCC 
NimB1 rev GCAATCGGACAGGTGTGAATACAGG 
NimB2 fw ACCAGCAGAACCATGTGGAACAGG 
NimB2 rev tCATAGCCATCGCAGCAGACTTGG 
NimB3 fw GCACTTGACATCCACGCTGATTGG 
NimB3 rev AGCAAATGGGCTCGCACTTCAGG 
NimB4 fw GCTGCAACTTCACGAGCAACAGC 
NmB4 rev CCCACAATCTTCACCTCCTTGTCG 
NimB5 fw GGACCAGCCAACTTCCAAGATCC 
NimB5 rev TCGCACTCACCAGGAATCTTACAGC 
NIMC1 fw CCCATCGGCTTGAATGTTTGTAACC 
NIMC1 rev GCAAGTATTGGGGGACGAGCAGAA 
NimC2 fw AGTTCTCCTGGCCGCTGTGAGTGc 
NimC2 rev GCCCATCGTTTGATAAAGCCCAGA 
NimC3 fw tGTATCCCATGCTGGTCCTCGTCC 
NimC3 rev CCTCCATGCTCATCTCGATCTGG 
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PGRP-LA fw GCACCATTCAGGATTCAGCCATTG 
PGRP-LA rev GCCAGCAGAAATTGGACACCTTCC 
PGRP-LE fw ACGCTCCCAAAACTCCGACACATT 
PGRP-LE rev TCTTACGTTGATCGCCCGCTTTTC 
PGRP-LF fw ATCACACGGCAACCGAAGGATG 
PGRP-LF rev GGGGCTTAATTGTCGATGGGCATA 
PGRP-SB1 fw TTGTGGCCGCTTTAGTGCTTTGCT 
PGRP-SB1 rev CGACCCTTGTGATCCGACTGAATG 
PGRP-SB2 fw CTTCAATCCGCATCAGTGCCAGTT 
PGRP-SB2 rev  CACGGAATAGTTGGGCGAAACCTG 
PGRP-SC1a fw TGGTTTCCAAAGTGGCTCTCCTCCT 
PGRP-SC1a rev ATCATGTTCGGCTCCAGGGTGTC 
PGRP-SD fw  AATCGCTGTCCAGGGGGAAGTACC 
PGRP-SD rev GGGCCACTGCTGTATCAGAGCGTA 
PGRP-LC fw CGCTCAAATATCAAACGAGCTGCAA 
PGRP-LC rev TATAACGCCCGAGTCTGTGGACGA 
PGRP-SA fw CGCTATGTGGTCATCCATCACACG 
PGRP-SA rev ATAAAGGCTATGCCCGTGCCAATG 
  
qRT-PCR primers:  
Cdc42 fw CCTTCGAGAACGTCAAGGAG 
Cdc42 rev GTGATGGGCTTCTGCTTGTT 
Malvolio fw GGACACAAACAAGGCTACCG 
Malvolio rev ATGCCGCACAATCTCTACCT 
Syb fw CCACGTTCACACGCATAATC 
Syb fw AGAAGAAGCTGCAGCAGACC 
zCOP fw AATGGGAATGTCATCGTTGC 
zCOP rev GCTGGAAAACCTGGAGATCA 
PSR fw ATGACAAACCAGCGGTAAGG 
PSR rev TATTTTCGCGACGACCTCTT 
DSCAM fw GGTCTGGTTCACGGGTTCTA 
DSCAM rev CACCTACAACATTCGCATCG 
rp49 fw GATGCCCAACATCGGTTACG 
rp49 rev TTGTGCACCAGGAACTTCTT 
GFP fw AGTGGAGAGGGTGAAGGTGA 
GFP rev GTTGGCCATGGAACAGGTAG 
 
8.6 Total RNA isolation and cDNA synthesis 
Total RNA was isolated from 2x105 S2 cells using the RNEasy kit (Qiagen). First 
strand cDNA synthesis was performed using 100 µg total RNA and the iScript kit 
(Biorad) according to the manufacturer’s instructions. We isolated total RNA from S2 
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cells that had been treated with RNAi against specific genes, mock treated with RNAi 
against gfp or left untreated. 
8.7 qRT-PCR 
qRT-PCR experiments and analyses were performed as described by Arany, 2008 
using Sso Fast Eva Green Supermix (Biorad) and the CFX96 thermal cycler (Biorad) 
and the primers listed in table 5. The amount of mRNA detected was normalized to 
control rp49 mRNA values. Normalized data were used to quantify the relative levels 
of a given mRNA according to cycling threshold analysis (ΔCt). Relative Δ Ct gene / 
Δ Ct rp49 ratios of untreated controls were anchored in 1 to indicate fold induction. 
Graphs represent the mean and SEM of relative ratios detected in 3 independent 
experiments.  
8.8 Real-time PCR 
Total RNA from all developmental stages of Drosophila was isolated using Trizol 
(Invitrogen) and the RNeasy kit (Qiagen). We used the iScript cDNA synthesis kit 
(Biorad) for reverse transcription and performed touchdown PCR with the primers in 
Table 5 and cycle numbers between 20 and 25 to obtain semi-quantitative gene 
expression profiles. 
8.9 Immunohistochemistry 
Immunohistochemistry was performed using the following antibodies: rabbit anti-
activated Caspase-3 (CM1; Cell Signaling Technology; 1:25 or Santa Cruz, 1:50), 
mouse anti-GFP (Molecular Pobes, 1:50). Fluorescent secondary antibodies against 
mouse, rabbit, rat, guinea pig (Alexa Fluor 488, Cy3 and Alexa Fluor 568, Jackson 
ImmunoResearch; Alexa Fluor 488, Molecular Probes) were all used at 1:200. DAB 
staining was carried out using Vectastain Elite kit (Vector Labs) and 1.5 mM NiCl2 for 
signal intensification. All solutions and buffers were generated according to protocols 
in Sullivan et al. (2000). Embryos were dechorionated for 3’ in 50% bleach (Chlorox), 
then fixed in 3.7% formaldehyde for 20-23’; washes were performed in PBS + 0.1% 
Triton- X100; unspecific staining was blocked using 10% normal serum and 
antibodies were diluted in PBS+ 0.1% Triton+ 5% normal serum. Primary antibodies 
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were incubated overnight at 4°C and secondaries 1 h at RT. Stained embryos were 
stored and mounted in 80% glycerol. 
8.10 Imaging of embryos 
All confocal images were acquired using a Zeiss LSM 510 upright or 710 inverted 
confocal microscope. 0.5 μm for the stage 16 nervous system imaging and 1.14 µm 
confocal sections for the stage 13 whole embryo images were taken and stacks of 
35 (stage 16) or 50 (stage 13) sections generated; image analysis was performed 
using LSM 510 or Zen software (Zeiss), ImageJ (NIH, USA, http://rsb.info.nih.gov/ij/)  
and Imaris 4.0/ 7.0 and ImarisBatch 1.3 (Bitplane).  
8.11 In vivo phagocytosis assay 
To quantitate the number of apoptotic particles and their engulfment by 
macrophages, confocal stacks (35 sections; total 17 µm) were acquired from the 
neural cortex of stage 16 ventral nerve cords, where most apoptosis occurs and 
where cell body glia reside. To quantitate the number of apoptotic particles outside 
the CNS, stage 13 embryos were imaged from lateral to medial, excluding the nerve 
cord (confocal stacks with 50 sections; total 57 µm). Three-dimensional 
reconstructions were built and the number and volume of activated Caspase-positive 
particles measured with an appropriate isosurfacing threshold using Imaris and 
Imaris Batch software. All data were collected with identical software parameter 
settings. Statistical significance of differences between experiments was assessed 
by one-way ANOVA with Dunett’s post hoc test, with n = 8–20.  
8.12 Fly infections 
COL strain S. aureus (generous gift from Alexander Tomasz, Rockefeller University) 
from frozen culture were grown over night in tryptic soy broth (BD Biosciences) and 
diluted to have the same concentration at 6 pm. The stock solution was diluted 1:100 
to reach a final concentration of ca. 2x106 c.f.u. (colony forming units) ml-1. For E. 
coli, the standard laboratory strain DH10B was used. Bacteria were grown for 16 h, 
spun down and resuspended in 100 µl LB media to ca. 4x107 c.f.u ml-1. For injection, 
adult male flies were used (4–5 days old). Flies were anaesthetized with CO2 and 
infected via injection in the dorsal thorax with a glass needle loaded with the 
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bacterial suspension. Flies were returned to standard fly culture vials with food and 
incubated at 25 °C. Flies were infected in batches of 30. Following infection the 
number of surviving flies was recorded at intervals. Experiments were repeated at 
least three times (total of 90 flies). For each genotype and experiment, statistical 
significance was evaluated using Cox regression analysis of survival and calculation 
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